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Abstract
This research aimed primarily to understand the governance mechanism adopted for
improving the public awareness on Antimicrobial Resistance (AMR) as the first goal of the
Egyptian National Action Plan (NAP) for curbing AMR. The secondary purpose was to assess the
public awareness, and to identify areas for improvement on raising awareness on AMR. A mixed
approach was adopted; firstly, eight in-depth interviews with different stakeholders`
representatives involved in the NAP development were held to understand the governance of the
NAP. Secondly, a public awareness survey was conducted on 565 respondents to assess their
knowledge and awareness on AMR and antibiotic use. The NAP policy design was well developed
It involved all concerned stakeholders, and identified their roles and responsibilities; however, it
lacked any reporting mechanism, and it was not legally bound. The Analysis revealed some
isomorphic mimicry behavior in the NAP implementation; meaning there is a clear disconnect
between what is stated in the plan and what gets to be implemented on the ground. Despite
integrating all One Health sectors in development, only the Human sector did some independent
activities for raising public awareness. Other sectors did not show any activities, except for
educating veterinary students on AMR in some universities. On the other hand, the survey
respondents were partially aware of the AMR, and they expected more efforts and communications
from the government on the AMR. In conclusion, the research identified areas for improvement of
the NAP`s goal to improve public awareness on AMR such as binding the NAP legally, setting a
transparent system for implementation, harmonizing the One Health activities, creating a
benchmarking environment for progress, defining the funding resources conspicuously. Finally,
increasing the media messages on AMR and proper antibiotic use via social media, local TV, and
local radio channels should be considered.
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Chapter 1: Introduction
1.1 Antimicrobial Resistance
Antimicrobial Resistance (AMR) is a global public health crisis (CDC, 2021; WHO, 2018).
It is a natural phenomenon that evolves by microorganisms to help them survive against threats;
however, it is possible to slow down the emergence of resistance by proper use of antimicrobials
by using them properly with the correct dose and for a suitable duration (CDC, 2013). Nobel
laureate Alexander Fleming rightly points out:
“The time may come when penicillin can be bought by anyone in the shops.
Then there is the danger that the ignorant man may easily under dose himself and
by exposing his microbes to non-lethal quantities of the drug make them resistant.”
(Fleming, 1945, p.93).

Currently, AMR is one of the critical challenges facing humanity and threatens modern
medicine practices such as chemotherapies and organ transplants. Therefore, immediate actions
from all government sectors and society are strongly mandated (WHO, 2021a). David Cameron,
former British prime minister, once announced, "If we fail to act, we are looking at an almost
unthinkable scenario where antibiotics no longer work, and we are cast back into the dark ages of
medicine” (GOV.UK, 2014). Ten million deaths by 2050 are estimated to occur due to multidrugresistant infections (O’Neill, 2016). Globally, drug-resistant infections costs are higher than nonresistant infections due to longer illness duration, more expensive drugs, and additional tests
required (WHO, 2021a). In the United States of America (USA), at least two million patients get
infected by resistant infections every year, and at least 23,000 patients die from it (CDC, 2013).
9

The CDC report (2019) on AMR summarized that more than 2.8 million infections due to antibiotic
resistance occur every year, and as a result, more than 35,000 deaths occur.

The CDC explained that AMR happens as follows: “Germs evolve all the time, developing
new ways to avoid the effects of antibiotics. Once new resistance develops, exposure to antibiotics
wipes out susceptible germs and allows the resistant germ to survive and multiply.” (CDC, 2019,
p.21). The WHO listed six main factors that enhance the emergance of AMR: “(1) over-prescribing
of antibiotics, (2) patients not finishing their treatment, (3) over-use of antibiotics in livestock and
fish farming, (4) poor infection control in hospitals and clinics, (5) lack of hygiene and poor
sanitation, and (6) lack of new antibiotics being developed.”(WHO, 2020).
According to the United Nation Environment Program (UNEP)`s emerging issues, (2022),
Not only is the AMR affected by the antibiotics overuse in the human health, animal feed, and
agriculture. It is additionally affected by the poor waste management of waste deposits from
hospitals, households, animal husbandry, and pharmaceutical industries. As described in the
picture below adopted from (UNEP, 2022).

Picture (1): How antibiotic use in human and animal health affects the environment,
adopted from UNEP (2022).

10

On the other hand, the pharmaceutical industries are relatively less interested in antibiotics
discoveries; because, the resistance will eventually evolve to the antibiotics. Therefore, the global
antibiotic pipeline1 is almost empty (ECDC, & EMEA, 2009). The Organisation for Economic Cooperation and Development (OECD) report in 2019 revealed a decline in the newly approved
antibiotics by the FDA, from 16 new antibiotics in 1983-87 to just 2 new antibiotics in 2008-12,
then increased to only 5 newly approved antibiotic in 2013-16 (Science business, 2019). Therefore,
with the increase in AMR and the decrease in the development of new antibiotics, the world faces
a catastrophic crisis of untreated infections caused by AMR.

1.2 Antibiotic use
The 2013 Center for Disease Prevention and Control (CDC) report on AMR (in the USA)
pointed out that "The use of antibiotics is the single most important factor leading to antibiotic
resistance around the world." (CDC,
2013, p.11). Antimicrobial use is not
restricted to humans only; they are
widely used for land animals, aquatic
animals, plants, and the environment;
therefore,

coordinated

action

is

required from all stakeholders and
multiple sectors (WHO, 2021a). The
CDC (2019) pointed out the use of Box (1): Antibiotic use across settings, adopted
from the CDC report on AMR, 2019, p.18.
1

Antibiotic pipeline is the inventory of recently discovered antibiotics or being discovered in the research centers of
pharmaceutical companies.
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antibiotic across different settings; Environment, People, and animals as shown in Box (1):

Antibiotic consumption in developing countries that do not restrict antibiotic purchases in
the community is relatively higher than in other countries that restrict antibiotic purchases in their
community, such as Europe (Farooqui, et al., 2018). Misuse of antibiotics in the community
contributes to the overuse of antibiotics, which is considered one of the leading causes of
emergence of resistance (CDC, 2013, 2019).

In Low-Middle Income Countries (LMIC) like India, rational antibiotic use faces several
challenges. For instance, antibiotics are prescribed as frequent Over the Counter (OTC)
medications. Healthcare providers` poor understanding (or knowledge) of antibiotics that lead to
misuse of antibiotics, and limited access to medical consultations for geographical or economic
reasons are serious challenges facing the containment of AMR. Moreover, low-income families
are key social determinants of antibiotic misuse in the community (Barker, et al., 2017). Also, poor
pharmacy practices in community pharmacies seem to influence antibiotic misuse, which happens,
among other things, lack of taking proper medication history when providing medications, lack of
patients’ reconciliations2 on their medications, and lack of referral to medical healthcare providers
(Erku, et al., 2017). The knowledge of different products available in the market is not enough to
provide excellent healthcare services; there should be solid and in-depth scientific information
while providing such services. This approach is achieved through continuous education of

2

Medication reconciliation is the process of comparing a patient's medication orders to all of the medications that
the patient has been taking. This reconciliation is done to avoid medication errors such as omissions, duplications,
dosing errors, or drug interactions.
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healthcare providers and instant modification of educational curricula for undergraduates (Miller
& Goodman, 2016).

Egypt is a Low-Middle Income Country (LMIC) with a population of 106,472,382 people
in August 2022 (Worldometers & Department of Economic and Social Affairs, 2022). Available
evidence suggests that there are misuse/overuse of antibiotic in Egypt. For example, in Menya, an
Upper Egypt governorate, the prevalence of inappropriate OTC antibiotic dispensing in
community pharmacies is quite high (93.4%) as mentioned by (Abdelaziz et al., 2019). On the
other hand, in Cairo, the capital of Egypt which is characterized by a very condensed population
and variations in the educational and economic levels, the community pharmacies play a crucial
role in dispensing OTC medications, including antibiotics (Sabry, et al., 2014). Moreover, in
another cross-sectional survey among community pharmacies in greater Cairo, the majority of
pharmacists (74%) agreed that there is an overuse of antibiotics in the community ( Zakaa El-din,
et al., 2019). Additionally, one study found that there is a tendency to antibiotics over prescription
by dentists in Egypt (Aly & Elchaghaby, 2021). When it comes to non-medical background
awareness on AMR and Antimicrobial use (AMU), a study conducted on non-medical university
students in Egypt concluded that it is urgently important to integrate health literacy on AMR and
rational AMU in curricula to help fight the AMR crisis (Mostafa et al., 2021).

1.3 Governance of antimicrobial resistance
In May 2015, the World Health Assembly3 developed a Global Action Plan (GAP) for
AMR to ensure the sustainability of global efforts which aim to contain AMR. The GAP provides

3

The WHO defined the world health assembly as the decision-making body of WHO. It is attended by delegations
from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board.
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a guiding framework for countries to develop their NAPs (National Action Plans), and it outlines
five key objectives as mentioned in the WHO website:


“to improve awareness and understanding of antimicrobial resistance through
effective communication, education, and training;



to strengthen the knowledge and evidence base through surveillance and
research;



to reduce the incidence of infection through adequate sanitation, hygiene, and
infection prevention measures;



to optimize the use of antimicrobial medicines in human and animal health;



to develop the economic case for sustainable investment that considers all
countries' needs and to increase investment in new medicines, diagnostic tools,
vaccines, and other interventions.” (WHO, 2016)

So far, 102 officially approved NAPs for AMR worldwide have been published in the
WHO library for NAPs (WHO, 2022). Most countries, especially low-income and low-middle
income countries, have developed NAPs that show an "isomorphic mimicry," defined as a solid
vertical alignment with the five overarching objectives of the global action. At the same time, there
are lower alignment levels in implementing these objectives (Munkholm & Rubin, 2020). On the
contrary, some high-income countries have developed NAPs that demonstrate an "isomorphic
posturing." These countries' policies may show some discordance with the GAP's five main
objectives but are highly effective in implementing the objectives based on previous achievements
(Rubin & Munkholm, 2021). Rubin and Munkhlom (2021) argue that the two opposing isomorphic
behaviors hinder the best practice of global harmonization.
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In 2018, Egypt developed its NAP for Antimicrobial resistance for the duration from 2018
to 2022 (Egypt National Action Plan For Antimicrobial Resistance, 2018). This NAP is adopted
from the GAP, and adapted to fit the Egyptian context. The Egyptian NAP included a vast
majority of different stakeholders engaged together for NAP development. Such as the Ministry
of Health and Population as a focal point, the Ministry of Agriculture, the Ministry of
Environment, the Supreme Council of Universities, the pharmaceutical industry room, the
Ministry of Interior, the Ministry of Education, and the concerned international organizations
(such as WHO, FAO, OIE), also known as the international secretaries for AMR. It examined the
situational analysis for the Egyptian context concerning the AMR and AMU as well as the
Infection Prevention and Control practices (IPC). It set four main objectives: first, improving
public awareness of AMU and AMR; second, optimizing the use of antimicrobials in human and
animal sectors; third, strengthening the One Health engagement; finally, implementing evidencebased practices for infection prevention and control.

The governance mechanism of the Egyptian NAP was described by establishing a national
steering committee for AMR under the direct supervision of the ministry of health. This national
AMR committee consists of representatives from all stakeholders involved and supervises the
activities of five technical working groups. Each technical working group includes experts from
all stakeholders. There is an independent technical working group for implementing each of the
four main objectives defined in the NAP: communication technical working group, antimicrobial
stewardship technical working group, surveillance technical working group, and IPC technical
working group. The fifth technical working group is responsible for fundraising and financing.
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For the first goal of the Egyptian NAP, which is: “Improve public awareness,
understanding of antibiotic use and antimicrobial resistance” is discussed in details at the fourth
chapter of the NAP (Egypt National Action Plan For Antimicrobial Resistance, 2018). It
recognized the importance of raising public awareness on the issue to change people’s behavior
towards the antibiotics' rational use. This activity would be implemented by targeting different
stakeholders such as students in schools, the public community, professionals, and policymakers.
It emphasized that AMR must be integrated into continuous professional training for healthcare
workers and veterinarians. The plan formulated four main strategic objectives for this goal:
1. Develop national awareness-raising, communication, and education
programs.
2. Encourage sustained behavior change for infection control,
biosecurity measures, and antibiotics stewardship programs.
3. Enhance community awareness on hygiene and vaccination
4. Advocate for adopting appropriate policies and legislations, and
allocating resources for AMR communication. (Egypt National
Action Plan For Antimicrobial Resistance, 2018).
The stakeholders responsible for implementing the abovementioned objectives are the
Ministry of Health and Population, the Ministry of Education, the Ministry of Higher Education,
the Ministry of Agriculture, the Ministry of Environment, and the communication technical
working group.
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1.4 Research problem
Despite the substantial global efforts to effectively control AMR, several factors hinder
having the desired impact. While most countries have developed their NAPs for AMR, few have
implemented them effectively (IACG, 2018). Additionally, the implementation of NAPs is
challenging owing to the multifactorial sectors involved in them, which are: the human, animal,
and environmental health sectors (Anderson, 2018; Frumence et al., 2021; WHO, FAO, OIE, &
UNEP, 2022). Moreover, the influence of diverse vital players in implementing the NAP other
than the government, such as civil society organizations, private sectors, health systems, and others
contributes to the difficulty of effective NAP implementation (WHO et al., 2022). Moreover, for
some low-income and low-middle-income countries, there are trends for isomorphic mimicry
described by non-conformity between the drafted NAPs and their implementation (Rubin &
Munkholm, 2021). Consequently, for successful containment of the AMR crisis, having a welldeveloped NAP aligned to the GAP is required, and assessing its effectiveness in implementation
is also required.

In Egypt, the WHO official website published a formulated NAP for AMR from 2018 to
2022. Understanding the governance mechanism adopted by the Egyptian NAP's stakeholders and
assessing its implementation shed light on areas for improvement for more effective containment
of the AMR threat in Egypt. On the other hand, information on the Knowledge, Attitudes, and
Practices (KAP) of AMR and Antimicrobial Use (AMU) in Egypt is scarce and limited to very
few publications in the literature compared to other countries. For example, one study examined
the KAP of Egyptian dentists of AMU (Aly & Elchaghaby, 2021). Another two studies examined
the KAP of community pharmacists on AMU in Cairo (Mohamed Zakaa El-din et al., 2019; Sabry
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et al., 2014). Finally, one study examined the health literacy on AMR and AMU among nonmedical university students in Egypt (Mostafa et al., 2021). Therefore, there is a need for more
exploration.

1.5 Research objective
This research aims to explore the governance mechanism of the Egyptian NAP for the
containment of the AMR and assess its effectiveness in raising public awareness of the AMR. The
findings of this study may help policymakers develop a better understanding of the problem and
help them to develop effective and sustainable strategies to increase the awareness of the AMR
and AMU in a harmonized collaborative One Health approach. McEwen and Collignon (2018)
introduced the One Health approach as “…the collaborative effort of multiple health science
professions to attain optimal health for people, domestic animals, wildlife, plants, and our
environment”. In addition, it can guide on issues they could consider to help to have proper
knowledge and attitudes towards AMR and good practices on AMU.

1.6 Research question and sub-questions
1.6.1 Main research question
In light of the research objectives, the proposed main research question to fill the gap is as
follows:
How the NAP stakeholders adopted the governance mechanism to improve public awareness of
AMR and AMU in Egypt? And to what extent citizens are aware of AMR and AMU?
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The question explores the governance mechanism of the Egyptian NAP for AMR to
implement the first goal of the NAP. The first goal aims to increase the awareness of different
audiences in human health, environmental health, and plant health, as well as the consumers of
AMR, to encourage behavioral change to the AMU in all sectors. Raising citizens' awareness of
AMR and AMU paves the way to implement other NAP goals effectively. Effective
implementation of the first goal of the NAP, raising public awareness, supports the implementation
of the other three goals of the Egyptian NAP. It is done by steering the optimization of
antimicrobials use for humans, animals, and the environment, the surveillance of both AMU and
AMR, and the effective implementation of infection prevention and control practices to reduce the
infection rates.
1.6.2 Sub-questions
1.

What are the strengths and weaknesses of the current government mechanism for
implementing the first goal of the NAP?

2.

How far is the governance mechanism of the NAP effective in raising public
awareness?

3.

What are the challenges that hinder raising public awareness effectively? And What
can be done differently?

Answering these three sub-questions will help identify the gaps in the knowledge, attitudes,
and practices of using antimicrobials in Egypt. Subsequently, developing the right messages and
information required for successful containment of the AMR threat in Egypt. In addition,
understanding the challenges in the implementation can help policymakers to work on dissolving
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these challenges and reaching the desired impact of AMR containment in all sectors and at all
levels.

1.7 Thesis outline
The present research is divided into six main chapters. The first chapter, introduction and
background, introduces the antimicrobial resistance threat and the global efforts to contain AMR.
It also introduces the Egyptian efforts to address this phenomenon and describes the Egyptian NAP
for AMR. Finally, it explains the research problem, and articulates the main question and subquestions. The second chapter analyzes the literature review, which elaborates on the governance
of NAPs for AMR globally and at the countries' level. The third chapter discusses the conceptual
framework of the study and the methodology adopted to investigate the governance mechanism of
the Egyptian NAP for AMR and assess the implementation of the first goal, which is raising public
awareness of AMR and AMU. The fourth chapter presents the results of the research qualitatively
and quantitatively. The fifth chapter discusses the findings of the results. Finally, the sixth chapter
concludes the study, defines the challenges, and provides some recommendations for better raising
of public awareness on AMR.

20

Chapter 2: Literature review
This Chapter introduces the general governance principles and those for healthcare
systems. Moreover, it elaborates the dimensions of the good AMR governance, and explains the
existing framework for NAPs assessment. Finally, it describes the awareness of the AMR and
AMU among people in different countries.

2.1 Governance of AMR
2.1.1 Governance principles
The United Nations Development Program (UNDP) defined governance as: “… the system
of values, policies and institutions by which a society manages its economic, political and social
affairs through interactions within and among the state, civil society and private sector. It is the
way a society organizes itself to make and implement decisions achieving mutual understanding,
agreement and action.” (UNDP & Eurostat, 2004, p.2). According to Blunt (2016, p.9), governance
is "… the exercise of political, economic and administrative authority to manage a nation's affairs.
It is the complex mechanisms, processes, relationships, and institutions through which citizens and
groups articulate their interests, exercise their rights, and mediate their differences.” It is explained
further as embracing all applicable methods to be used by societies to manage their problems and
resources effectively and efficiently, in addition to responding to their critical needs and promoting
sustainable development. Governance has to encompass everyone in society, from the family to
the state. It should involve public and private sectors to tackle societal problems collaboratively.
Effective governance is built on three main cornerstones; public participation, accountability, and
transparency. (Blunt, 2016; Greer et al., 2016; Olowu, 2002; Pyone & Smith, 2017).
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Healthcare system governance was discussed widely among researchers. In healthcare
systems, various definitions of governance have been found covering different perspectives.
Nevertheless, most researchers agreed that healthcare system governance is about performance,
which leads to society's common good and well-being (Birgand et al., 2018; Frankowski, 2019;
Greer et al., 2016; Health system governance collaboration, 2022; Health systems 20/20, 2012;
Lewis & Pettersson, 2009; Siddiqi et al., 2009; Sitienei et al., 2018; WHO, 2007, 2008). While
healthcare system governance was tackled from different aspects, it is essential to present the main
domains that reflect good governance. There are multiple principles for good governance, which
are: Strategic vision, participation of all stakeholders, the rule of law, transparency,
responsiveness, equity and inclusiveness, effectiveness and efficiency, consensus-oriented, and
accountability are the fundamental principles of good governance (Biswas, 2022; Lewis &
Pettersson, 2009; Bennett, 2015; Siddiqi et al., 2009). Greer et al. (2016) suggested that
governance has five major attributes that can be used to trace governance problems (1)
accountability; (2) transparency; (3) participation of affected interests; (4) integrity; and (5) policy
capacity". Tashobya et al. (2014) proposed six attributes for assessing health systems performance
assessment learned from high-income countries' health system performance assessments. These
attributes are almost the same as those defined by Greer except for the last one. Tashobya et al.
listed them as follows: (1) different stakeholders' engagement; (2) political commitment; (3)
defined roles and responsibilities of each stakeholder; (4) accountability; (5) responsiveness; and
(6) benchmarking and competition. Tashobya et al. (2014) added the sixth attribute, benchmarking
and competition, for good governance to encourage the sustainability of the performance and
motivate different parties to keep improving their work.
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Since AMR is a global crisis threatening global public health (O'Neill, 2016), global health
leaders had a consensus on the importance of two main aspects to combating AMR: having robust
actions across different levels; global, national, and national, sub-national, and individual
levels.(ReAct, 2016). Secondly, including all concerned stakeholders from different sectors;
human, animal, and environment (IACG, 2018, 2019; O'Neill, 2016; ReAct, 2016; WHO et al.,
2022). They have developed a global action plan as an all-out effort to address the AMR. The
global action plan set five main objectives; improving public awareness of AMR, enhancing AMR
surveillance, encouraging infection and prevention control practices, optimizing antimicrobials`
use, and promoting research and investment in the field. Moreover, the GAP has described the
corresponding actions required for each objective for different key stakeholders; member states,
the secretariat within the tripartite collaboration, and other international and national organizations
(WHO, 2016).

As a consequence of the GAP development, every country has to develop its own NAP
aligning with the global one, as mentioned earlier in chapter one. It should encompass engaging
the whole society, fostering infection prevention and control practices, preserving access to
antibiotics, maintaining the sustainability of the national action plan implementation, and enabling
progress on NAP implementation by continuous evaluation and monitoring (WHO, 2016). Many
researchers argued for legally binding the governance structure to strengthen the governance
implementation (Greer et al., 2012; Munkholm & Rubin, 2020; Rubin & Munkholm, 2021;
Veillard et al., 2011). This approach supports the solid coordinated actions required for combating
AMR. Several countries have responded and developed their own NAPs for AMR, and published
them on the WHO website (WHO, 2022), such as Jordan and Kingdom of Saudi Arabia from the
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Eastern Mediterranean, Cameroon and Ghana from Africa, Bangladesh and Indonesia from Southeast Asia, Australia and Cambodia from the Western Pacific, France and Germany from Europe,
and other countries.

The alignment of a country's NAP to the GAP is known as "vertical alignment". It examines
how far the NAP objectives are similarly consistent with GAP. On the other hand, the "horizontal
alignment" scrutinizes the syntactic overlaps between different NAPs (Munkholm & Rubin, 2020).
Munkholm and Rubin (2020) have proposed that horizontal alignment is the most useful when
implemented among different stakeholders, sectors, and regions from the global perspective
because it could help decrease governance fragmentation and minimize the isomorphic mimicry
during implementation. Consequently, they have called for a global governance mechanism that is
legally bound for all sectors to support the NAPs' implementation. Moreover, because of poor
horizontal alignment within regions, Munkholm and Rubin (2020) argued for having active
regional offices, such as the WHO, FAO, and OIE. These regional offices must act as mediators
towards minimizing policy fragmentation and isomorphism mimicry between regional countries
(Munkholm & Rubin, 2020; Ponnu, et al., 2018).

2.1.2 NAP implementation and monitoring
Rubin and Munkhlom (2021) discussed the isomorphic dynamics observed in developing
and implementing NAPs. They have observed in most of LMICs an apparent discordance between
the NAP development and its implementation. This behavior is known as "isomorphic mimicry".
In contrast, high-income countries showed remarkable deviations in implementing the GAP, which
is described as "isomorphic posturing". These countries have their NAPs developed with little
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wording than what is done in reality and are not in parallel with the GAP's objectives. Rubin and
Munkhlom argued that isomorphic dynamics, either mimicry or posturing, hinder the best practices
of global alliances for combating AMR. Their findings revealed three scenarios for vertical
isomorphism. First is the isomorphic behavior, where a NAP aligns with the best practices in form
and function, such as in Japan. Second is the posturing behavior, where a NAP aligns with the best
practices in functions but with a different form, such as in Denmark. The third is the isomorphic
mimicry behavior, where the NAP aligns with the best practices in the form but functions
differently, such as in Myanmar (Rubin & Munkholm, 2021).

The WHO, the FAO, and the OIE, also known as the tripartite organizations, have created
a universal platform that allows every country to present its progress in NAP implementation every
year. It is a multisectoral self-assessment questionnaire sent to each country to fill in. This platform
can reflect each country's capacity, performance, and progress in each sector of One Health. This
platform is named the Tripartite AMR Country Self-Assessment Survey (TrACSS) (WHO, FAO,
& OIE, 2019). The Interagency Coordination Group on AMR (IACG) reported that NAP
development is not as challenging as NAP implementation and sustainability in most countries
(IACG, 2018, 2019). This is going back to the complex nature of the AMR and the interconnection
among multiple sectors and stakeholders across different levels, the lack of enough funding for
NAP implementation, the existence of logistical, technical, and institutional challenges, and the
lack of a mechanism for synchronization and implementation (Anderson et al., 2019). Several
researchers from low and middle-income countries have discussed the NAP implementation in
their countries and revealed implementation challenges and areas for improvement for better NAP
implementation. They had a consensus on the difficulty of collaboration between One Health
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sectors and the lack of consistent funding for the NAP activities as the main challenges met during
the NAP implementation (Orubu et al., 2020; Frumence et al., 2021; Jimah & Ogunseitan, 2020;
Nair et al., 2021).

Anderson et al. (2019) have developed a governance framework that guides the NAP
development and assessment, and consists of three main areas, policy design, implementation, and
monitoring and evaluation. The three areas cover eighteen domains with a total of 52 questions.
Each domain discusses critical points to be considered in NAP development and assessment
(Anderson et al., 2019). Chua et al. (2021) have further modified the governance framework and
detached the One Health approach and sustainability as two separate areas that each NAP has to
tackle, in addition to the previously mentioned areas by Anderson et al. (2019); Policy design,
implementation, and monitoring and evaluation. (Chua et al., 2021).

The literature lacked any scientific evidence on the governance mechanism of the Egyptian
NAP for AMR, and its effectiveness in the NAP`s goals implementation which represents a
conspicuous literature gap and which this thesis plans to fill.

2.2 One Health
One Health is an attitude that describes the harmonization between people, animals,
and environmental health, where they affect and are affected by each other (McEwen & Collignon,
2018). The CDC defined "One Health" on its website as: "… a collaborative, multisectoral, and
transdisciplinary approach — working at the local, regional, national, and global levels — with
the goal of achieving optimal health outcomes recognizing the interconnection between people,
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animals, plants, and their shared environment" (CDC, 2022). Despite the complexity of the
structure, this definition is helpful because it guarantees collaboration between different sectors
and across different levels horizontally and vertically.

Whereas the involvement of One Health's sectors in the NAP development is crucial, the
actual implementation of the collaborative activities is challenging. Many countries struggled to
apply the One Health approach in a collaborating manner, rather than individually, during the NAP
implementation (European Public Health Alliance, 2018; Joshi et al., 2021). At the same time,
other countries failed to tackle the environment health and animal health, focusing only on human
health (Frumence et al., 2021; Nair et al., 2021). On the other hand, Sweden is considered a role
model in the collaborative One Health implementation for containing AMR. Sweden has set strong
policies with clearly identified roles and responsibilities that are very well integrated into the
relevant governmental systems of One Health. Moreover, It has equipped these systems with the
proper resources; human, infrastructure, and operational. (Eriksen et al., 2021).

In Egypt, there has not been any scientific evidence examining the One Health awareness
and implementation within the Egyptian NAP on AMR.

2.3 Policy design of NAP
In 2022, the tripartite and the United Nations of Environment Program (UNEP) will
continue to support countries in several political aspects. First, to have a coherent policy design
across different sectors of One Health. Second, to have a higher political commitment to managing
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AMR as a priority on the national agenda. Third, to have a capacity for building robust regulations
and legislation for the AMR (WHO et al., 2022).
The policy design of NAP is very crucial to its success. Appropriate policy design
supported by enforced legislation paves the way for the successful containment of AMR. The
policy design has to encounter several principles within the NAP development and
implementation. First, the policy design has to present a strategic vision based on a local situational
analysis of countries and align with the global efforts to combat AMR in the GAP. Second, it has
to be controlled by a higher committee that incorporates all One Health stakeholders and enforces
legalizations and regulations among them coherently and collaboratively. Third, it has to provide
clear roles and responsibilities for each stakeholder in an accountable and transparent way. Finally,
it has to ensure the implementation of goals and objectives set in the defined timeframe within a
periodical feedback mechanism. (Anderson et al., 2019; Chua et al., 2021; Munkholm & Rubin,
2020; Ponnu et al., 2018; WHO, 2018).

Some countries were challenged in implementing some policy dimensions, such as
reporting and feedback mechanisms, transparency, resource reallocations, accountability, and
sustainability (Frumence et al., 2021). At the same time, because some developed countries have
different mechanisms for implementing accountability, Birgand et al. (2018) argue that
comprehensive accountability mechanisms should reach the front lines managerial levels rather
than the national managerial levels only. It needs to be mentioned that there is a lack of published
scientific literature defining the policy design of the Egyptian NAP on AMR.
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2.4 Implementation
Several developed and developing countries have conducted awareness campaigns on
AMR successfully, which had positive impacts on public attitudes and behaviors toward AMR and
antibiotic use in all sectors; human, animal, and environment (European Public Health Alliance,
2018; Frumence et al., 2021; Jimah & Ogunseitan, 2020; Omari et al., 2019; Zajmi et al., 2017).

There are multiple opportunities to raise public awareness of AMR and its threat to the
planet, including among healthcare providers and policymakers. For instance, the International
Secretariats, including the WHO, FAO, OIE, and UNEP, also known as the quadripartite, have
listed conducting national awareness campaigns targeting One Health stakeholders; human health,
animal health, plant health, food production, food safety, and environmental health, as one of
several output indicators for monitoring and evaluating the GAP implementation. They have
defined the TrACSS platform as the primary source of information for this output (WHO et al.,
2022). Moreover, The CDC has created the "Get Smart" program that adopts a national awareness
campaign on rational antibiotic use, which is the World Antibiotic Awareness Week (WAAW). In
November every year, the CDC and other institutions that support the rational use of antibiotics
celebrate the WAAW to raise awareness of AMR and the urgency to decrease the inappropriate
use of antibiotics (CDC, 2013). Interestingly, some literature suggested integrating AMR and good
hygiene practices in school curricula for children (Anderson et al., 2019; Chua et al., 2021;
Munkholm & Rubin, 2020; WHO, 2018).

For educating Health Care Providers (HCPs) on AMR, there have been continuous calls
for educating healthcare providers to provide them with the proper knowledge and information on
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the use of antimicrobials and the AMR crisis, not only in the human health sector but in the One
Health sectors as well. The education can be implemented within the pre-graduation and postgraduation studies. Additionally, it can be through organizing annual conferences and scientific
events on the AMR progress, lessons learned, and experience gained. Moreover, best practices can
be implemented by disseminating national or international guidelines to HCPs and sharing success
stories among them (Joshi et al., 2021; OIE, 2016; WHO et al., 2022; WHO, 2016).

In 2016, the OIE developed a strategy to support the GAP objectives in the containment of
AMR. The OIE strategy has set four main objectives; the first was to improve awareness and
understanding of prudent antimicrobial use in animals (OIE, 2016). Its work plan for raising
awareness included supporting veterinary professional development to address the AMR issue at
different levels, supporting the ethical use of antimicrobials, and collaborating with the WHO and
FAO (OIE, 2016).

In Egypt, very limited scientific evidence was available on the knowledge and the practice
on the rational antibiotic use in human health (Aly & Elchaghaby, 2021; Fathi et al., 2017;
Mohamed Zakaa El-din et al., 2019; Mostafa et al., 2021; Sabry et al., 2014). However, there was
no scientific evidence found on AMR awareness in the animal health and the environment health.

2.5 Monitoring and evaluation
The international secretaries, which are the WHO, the FAO, the OIE, and recently the
UNEP, always provide support to help countries monitor and evaluate their NAPs' activities. When
it comes to the first goal of the GAP, they suggested conducting systematic Knowledge, Attitude,
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and Practice (KAP) studies to understand the knowledge, attitudes, and practices of the community
and the HCPs toward antibiotics use and resistance (WHO et al., 2022). In 2015, the WHO
developed and conducted a global public awareness survey to understand the public's perspectives
on AMR and antibiotic use and hence provide guidance on awareness areas required for
improvement (WHO, 2015). Several countries have conducted such studies to help raise awareness
among their communities (Abdelaziz et al., 2019; Taha et al., 2016; Jamhour et al., 2017; Lum et
al., 2017; Tshokey et al., 2017; Yusef et al., 2018).

Many researchers argue for a robust monitoring and feedback mechanism for the AMR
activities implementation to continuously improve the NAP (Anderson et al., 2019; Chua et al.,
2021; Frumence et al., 2021; Munkholm et al, 2021; WHO, 2018).

In Egypt, such KAP studies were very limited in number and covered only few
governorates. These studies tackled the KAP of HCPs and some universities' students on antibiotic
use (Abdelaziz et al., 2019; Fathi et al., 2017; Sabry et al., 2014). Egypt participated in the global
public awareness survey conducted by the WHO in 2015 (WHO, 2015); however, no such survey
was repeated to assess the NAP's impact on the public's awareness since its development in 2018.

2.6 Sustainability
The WHO has set six steps to maintain the sustainability of NAP implementation (WHO,
2022a), which are: firstly, strengthen the NAP governance mechanism by establishing a
multisectoral coordinating committee that is functioning actively, and technical working groups
having clear terms of references, financial plan, and accountable framework for their activities.
Secondly, prioritize activities through assessment of the available resources, situational analysis,
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and feasibility and impact of suggested activities. Based on the assessment findings, a consultative
prioritization plan has to be developed and initiated. Thirdly, integrate the budget of each
prioritized activity in operational plans, and clearly define the Who, What, When, and Where
fields. Fourthly, mobilize funding resources by identifying the potential funders and filling the
funding gaps. It is useful to mention that domestic financing can be leveraged by integrating the
NAP with other ongoing national programs. Fifthly, implement prioritized activities by
collaborating with different stakeholders, internally and externally, and working together on the
ongoing implementation of the prioritized activities. Lastly, monitor and evaluate the
implementation progress regularly and communicate the progress reports and lessons learned to
all stakeholders.

Most of the developed NAPs have faced critical challenges in their implementation due to
financial reasons, where planned activities were not executed because of the unavailability of
adequate financing. While some NAPs did not set any budgeting for the NAP, other NAPs have
set monetary values for the NAP implementation. (European Public Health Alliance, 2018;
Frumence et al., 2021; Jimah & Ogunseitan, 2020; Nair et al., 2021; WHO, 2021). Interestingly,
some countries have dedicated a specific percentage of the national GDP to the NAP
implementation, such as in Tanzania, or the national budgeting framework, such as in Lithuania
and Denmark (European Public Health Alliance, 2018; Frumence et al., 2021). Other countries
have received their funding from international organizations such as the FAO, the USAID, the
WHO, and others. (WHO, 2018).
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In Egypt, there is no scientific literature found to tackle the NAP sustainability, and define
the challenges met during the implementation of the Egyptian NAP on AMR.

2.7 Public awareness
Jim O'Neil (2016) proposed four global interventions to tackle the AMR crisis.
The first intervention was to conduct a global public awareness campaign on AMR. O’Neill (2016)
emphasized that educating everyone about the AMR, especially children, and teenagers, is an
urgent priority that needs to be considered by industry experts, non-governmental organizations,
and international campaign developers. These campaigns should be able to convince people not to
buy antibiotics without an actual need and educate farmers not to use antibiotics unnecessarily in
agriculture. He urged that these campaigns are cost-effective and have a long-lasting impact
(O'Neill, 2016). He suggested that messages should be tailored to each region's or nation's
audiences. They can be delivered through different communication channels such as television and
radio advertising, social media, and the internet. They can also be conducted through traditional
means such as posters and flyers in hospitals and using a public figure to raise the AMR profile
(O'Neill, 2016).

In 2015, the WHO conducted a multi-country survey on public awareness of antibiotic
resistance as part of objective one implementation of the GAP. It revealed that around two-thirds
of the respondents across 12 countries had taken antibiotics in the past six months. Lower-income
countries used antibiotics more frequently than higher-income countries, where young people took
antibiotics more than old ones. The level of awareness of antibiotic use was more pronounced than
the level of awareness of AMR among the respondents (WHO, 2015).
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In Italy, a public awareness survey was conducted to assess the awareness of AMR among
university students in urban areas of the northern regions in 2016. The findings reflected a high
level of awareness of antibiotic use and AMR among the respondents. However, the authors
recommended that there should be more stress on the fact that AMR can be hindered by taking
antibiotics appropriately, completing the antibiotic course as prescribed, using antibiotics for
bacterial infections only, and avoiding the misuse of antibiotics. In addition, they emphasize
several points to raise public awareness; people should be more aware of the global AMR crisis,
people should use the antibiotic responsibly, and farmers should limit their antibiotic use for
animals (Prigitano et al., 2017).

In Egypt, the literature lacked any recent scientific literature on the awareness of the
Egyptians on the Egyptian NAP on AMR. The most recent literature available was published in
2015 by the WHO within the conducted multi-country survey on public awareness on AMR
(WHO, 2015). Nevertheless, that survey was conducted before the development of the Egyptian
NAP for AMR in 2018. Therefore, there might be some differences in the awareness level on AMR
after the NAP implementation. Additionally, no literature was found to understand the
communication channels on AMR awareness for the Egyptians. Consequently, this represents a
major literature gap for the Egyptian context that needs to be examined.
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Chapter 3: Conceptual framework and Research Methodology
3.1 Conceptual framework
In order to assess the governance mechanism and the implementation of the first objective
of the Egyptian AMR NAP, the framework developed by Chua et al. (2021) is adopted. Since the
NAP development is somehow a recent approach, there is limited literature discussing the AMR
NAP implementation and its effectiveness. Anderson et al. were the first to develop a framework
to assess the NAP implementation in 2019 (Anderson, et al., 2019). Nevertheless, Chua et al. has
modified the firstly developed framework to assess the AMR NAP implementation by Anderson
et al. (2019). They have emphasized the importance of two crucial domains; the One Health
approach in NAP development and implementation, as well as, the sustainability of the NAP
implementation; in addition to, the three main domains tackled by Anderson et al. (2019) which
are the policy design, the implementation, and the monitoring and evaluation. These two crucial
domains were initially subordinated from the policy design domain mentioned by Anderson et al
(2019). Yet, Chua et al. have pinpointed the importance of sustainability and One Health
engagement that classified them as separate domains, and have placed the One Health engagement
in the center of the other four domains reflecting the integration of One Health concept in each of
the other four domains. The Chua framework addresses five main governance areas to assess the
implementation of the NAP; Policy design, Implementation tools, monitoring and evaluation,
sustainability, and One Health engagement placed in the center of them.
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Figure (1): The governance framework of AMR NAP
antimicrobial resistance.
Sustainability
Funding
Improvement of
gaps and scaling up

Monitoring and
Evaluation
Reporting
Feedback
mechanism
Effectiveness

One Health
(Human-AnimalEnvironment)

Policy
Strategic vision,
Coordination,
Accountability,
transparency, and
participation

Implementation
Education
Public awareness
Source: Adopted from Chua et al., 2021, p.5 and tailored by the author to tackle the NAP's first
goal: raising public awareness and understanding of antibiotic use and antimicrobial resistance.

The researcher has tailored the framework to focus on the first objective of the NAP only;
to improve public awareness and understanding of antibiotic use and antimicrobial resistance. Each
governance area addresses different domains crucial for the effective implementation of NAP.
First: The policy design addresses the general governance domains and basic procedures
needed for the effective implementation of NAP (Ahmed & Naher, 2022; Anderson, 2018;
Anderson, et al., 2019; Chua et al., 2021; WHO, 2018). These domains are as follows: First, a
strategic vision has been formulated through conducting a local situational analysis of the AMR
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burden. Second, a coordination mechanism among different sectors and across different levels in
each sector is steered by a ministry or an intersectoral committee. Third, an accountable and
transparent system that clearly defines the roles and responsibilities of each stakeholder involved
in the NAP, the goals and objectives to be achieved through the defined timeframe, and the publicly
available information on the NAP itself, NAP progress reports, funding information, and
surveillance data. Last is the broad participation of high-level stakeholders to facilitate the
development and implementation of the NAP. The policy design formulation should incorporate
the engagement of One Health and should be legally bound (Anderson et al., 2019; Chua et al.,
2021; Harant, 2022; Sitienei, Nangami, & Manderson, 2018; WHO, 2018).

Second: The implementation area for raising public awareness and understanding of
antibiotic use and antimicrobial resistance focuses on two main domains: education strategies and
public awareness. Education strategies for all involved professionals are continuously updated and
available through different accredited institutions and the development of national guidelines. On
the other hand, public awareness is conducted through multimodal awareness campaigns that
consider psychological, behavioral, and social sciences. These campaigns must be ongoing and
implemented at all levels in the country. In addition, they are considering the integration of
educational campaigns within the schools' curricula. Both domains should cover the tripartite One
Health communication. (Anderson et al., 2019; Chua et al., 2021; Frumence et al., 2021;
Munkholm, Rubin, Bækkeskov, & Humboldt-Dachroeden, 2021; WHO, 2018).

Third: Monitoring and evaluation of the NAP implementation cover three aspects. The
working groups report progress reports of all included sectors to the governing committee and
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publish them. This activity allows different levels of sharing successes and challenges to avoid in
the future. Secondly, public awareness and education activity feedback mechanisms are in place
and do not exceed deadlines at local, regional, and national levels. This activity helps evaluate the
implemented activities' quality and quantity, timeliness, and the inclusion of the One Health
culture. Thirdly, the effectiveness of the awareness and education on the knowledge, attitude, and
practices of the healthcare providers and citizens. Measuring effectiveness shall be done
continuously according to the predetermined NAP. The impact of these interventions is reflected
in the other goals of the NAP, such as the antimicrobial use practices, antimicrobial consumption
rates, and infection and prevention control measures in all three dimensions of the One Health
approach. (Anderson et al., 2019; Chua et al., 2021; Frumence et al., 2021; McEwen & Collignon,
2018; WHO, et al, 2019).

Fourth: The sustainability of the NAP is tackled by two main domains; funding and
improvement of gaps identified. A dedicated budget for the NAP implementation at all levels must
be defined. It should rely on the NAP legitimacy applied to all relevant sectors. Moreover, it can
be aligned with national initiatives such as sustainable development goals. In addition to funding,
continuous improvement of different activities to fill the gaps of implementation, as well as
expansion and scaling up of activities of the NAP across different tripartite sectors. (Greer, et al.,
2016; WHO, 2022a; WHO et al., 2019; Anderson et al., 2019; Chua et al., 2021; Munkholm et al.,
2021; WHO, 2018).

Finally, the One Health engagement addresses all sectors involved in human, animal, and
environmental health. It is a multifactorial mission that must be addressed in every area of the
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governance mechanism. For this reason, it is placed at the center of the governance framework
because it influences each of the other governance areas' implementation.
Figure (2): Sectors of One Health

Source: adapted from (Munkholm, et al. 2021, p.239)
The NAP governance shall ensure a robust integration and collaboration of the tripartite
One Health in an ongoing manner. (Anderson et al., 2019; Chua et al., 2021; Munkholm et al.,
2021; WHO, 2018).

After understanding the governance mechanism of the NAP, a population-based survey to
assess the public awareness of AMR and antibiotic use will be required to reflect the effect of such
a governance approach on reaching the NAP's first goal. That is raising public awareness for
consumers and health care providers. This approach also will aid in understanding the awareness
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gaps and challenges. Consequently, guiding the improvement and sustainability of NAP
implementation (Effah et al., 2020; Prigitano, et al., 2018; WHO, 2015).

3.2 Research design
Understanding the governance mechanism of the Egyptian AMR NAP and assessing the
implementation of the first goal of the NAP, raising public awareness, has to be examined
differently. Because most literature sought the qualitative approach through conducting in-depth
interviews with stakeholder to understand the implementation of the NAPs; therefore, defining the
governance structure and actions taken by different stakeholders in Egypt is required. However,
assessing the level of awareness of the Egyptians is lacking in the literature, therefore examining
the public awareness and attitude towards AMR and antibiotic use is also required because people's
knowledge and awareness are reflected in their practices. Therefore, qualitative and quantitative
research methods were used to answer the proposed research questions.

In-depth interviews with key stakeholders involved in the NAP preparation were
conducted to understand what steps were taken to increase public awareness, what challenges they
faced, and what their future steps will be. The information given through the interviews is validated
with the WHO self-assessment tool (WHO, 2021). This approach represents the qualitative part of
the methodology, which aims to understand the governance mechanism adopted by the NAP
stakeholder towards achieving its goals.

On the other hand, a population-based survey to assess the public awareness of antibiotics
and antibiotic resistance, their common behaviors towards the use of antibiotics, and their
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preferences for receiving information and knowledge was conducted to assess the outcome of the
governance mechanism. Aiming to reach the ultimate impact of rational use of antimicrobials in
human, animal, and environmental health. This approach is the quantitative part of the research
owing to the scarcity of studies conducted on knowledge, attitude, and practice of AMR in Egypt.

3.2.1 Participants
3.2.1.1 Key stakeholders of NAP for raising public awareness
Eight representatives from different stakeholders were interviewed on the governance
mechanism in increasing public awareness of the NAP in Egypt. One representative was
interviewed from each of the following: The WHO Egypt office, the FAO Egypt office, the
Egyptian Drug Authority, a pharmaceutical industry company, the Ministry of Agriculture, the
Ministry of Environment, a national media newspaper covering the health sector, and the
academia. Representatives from the Ministry of Health and Population were difficult to reach.
Therefore, the researcher used secondary resources such as the country self-assessment tool for
the Tripartite Antimicrobial Resistance (WHO, 2021b), the ministry's official Facebook page
(MoHP| Facebook,2022), online local newspapers, in addition to the Egyptian NAP (Egypt
National Action Plan For Antimicrobial Resistance, 2018).

3.2.1.2 Questionnaire to Assess Awareness of AMU and AMR
A questionnaire has been developed reflecting the awareness level on antimicrobial
resistance, expectations from government on AMR, people`s means for having AMR information,
and their preferred means for having information on AMR. A total of 565 responses were received
from the online questionnaire that took, on average, 11 minutes to complete. There were 494
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responses following the inclusion criteria for the survey. The sample size calculated was 377
responses with a confidence level of 95% and a margin of error of 5% with a 50% response
distribution. This sample size aligns with the WHO's previously conducted public awareness
survey in 2015 to measure the public awareness of antibiotic use and resistance in Egypt (WHO,
2015) which was 511 respondents in Egypt.

The inclusion criteria included all adults above 18 years old living in Egypt. Therefore, the
exclusion criteria excluded any respondent below 18 years old or living outside Egypt. Those
Egyptians living outside Egypt are excluded from the study because they are exposed to different
governing bodies that may affect their awareness level. The convenient sampling in this research
was adopted because of the ease and time effectiveness of the method. In addition to indicating if
the Egyptian population is aware of the AMR and the NAP or not. Because the Egyptians have
similar traits in their knowledge of the research topic, being governed and exposed to the same
attributes in Egypt.

3.2.2 Data collection tools
Semi-structured interviews were conducted with different stakeholders’ representatives.
The interviews were conducted virtually when the representatives were asked several questions
about the governing mechanism of the NAP. Such as if a national steering committee was
established for the governance of the AMR NAP, what efforts were conducted to increase the
awareness of AMR, what challenges were met during the implementation of their objectives, and
how to overcome these challenges, how they measured the effectiveness of their interventions, and
how far or close they were from raising public awareness on antibiotic use and resistance. The
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interview questions were derived from the domains introduced by Anderson et al. (2019) in their
developed framework.

Secondary data resources were explored to compensate the unreachable representatives
from the Ministry of Health and Population, such as the official Facebook page for the ministry of
health and population. Additionally, the country's self-assessment tool for tripartite antimicrobial
resistance was used to complement any missing information from the interviews (WHO, 2021b),
in addition to the Egyptian NAP for AMR (Egypt National Action Plan For Antimicrobial
Resistance, 2018).

An online survey questionnaire was used. It is adapted from the WHO survey tool to
understand the common public behavior and understanding of antimicrobial resistance and
antibiotic use (WHO, 2015). Additional questions were added to ask the respondent about the
current means for having information on antibiotics and his/her preferred means to have such
information. These questions were adopted from World Bank Group Country Opinion Survey
2016: Egypt (World Bank Group, 2016).

The questionnaire was created using the Survey Monkey online surveying tool, and
distributed via social media from November 2021 to March 2022. The questionnaire is divided
into seven main domains, which are: demographics, knowledge about antibiotics, antibiotics use,
antimicrobial resistance, and antibiotic use in agriculture, as well as expectations from the
government, and finally, means of communication and information dissemination.
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3.2.3 Data analysis
The interviews` findings were conducted in Arabic and translated into English by the
researcher. Interviews were transcribed and coded by the researcher adopting the deductive
approach for a thematic analysis of the interviews. The findings were thematically sorted into five
main themes following the five main areas of governance as identified in the conceptual
framework: policy design, implementation, monitoring and evaluation, sustainability, and One
Health approach. The policy design theme was further divided into four main sub-themes:
accountability, transparency, coordination, and strategic vision. Likely, the implementation theme
was divided into four sub-themes: Education, public awareness, and HCPs' awareness of
antimicrobial stewardship programs and infection and prevention control practices. Moreover, the
monitoring and evaluation theme was subdivided into reporting, feedback, and effectiveness.
Lastly, the sustainability theme was subdivided into a mandate for implementation, a dedicated
budget, and an advisory group for technical implementation, monitoring, and evaluation subthemes. On the other hand, One Health's main theme was reflected by the human, animal, and
environmental participation in developing and implementing the NAP.

A descriptive analysis was conducted for the surveys using the statistical software IBM
SPSS version 22. The data generated were divided as follows: the demographics of the
respondents, the use of antibiotics among respondents, the knowledge about antibiotics, the
knowledge about antimicrobial resistance, the knowledge of the use of antibiotics in agriculture,
expectations from the government, and means of communication and information dissemination.
Further stratification of the gathered information is done based on the educational background.
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Those with medical backgrounds and practitioners are expected to have additional awareness and
more educational interventions than those with non-medical backgrounds and consumers.

Both methods' findings were analyzed to complement each other to answer the research’s
main question and sub-questions.

3.2.4 Ethical consideration
The interviews were voluntary and conducted between December 2021 and March 2022
after the Institutional Review Board (IRB) approval (Appendix 1). Interviewees were informed
about the nature and purpose of the research through the informed consent (Appendix 2) that the
IRB approved. The interviews were audio-recorded and kept confidential.

The respondents to the online questionnaire had to approve the informed consent before
proceeding with the questionnaire. It was added to the cover page of the questionnaire. The
informed consent described the research's nature and purpose and informed the respondent that the
results would be kept confidential and anonymous (Appendix 3).

3.2.5 Limitation of the research
The limitation of the research is related to the fact that the research did not cover all pillars
of the NAP implementation. It reflected on the preliminary step in implementing the NAP, which
is raising public awareness, only covering the first objective of the NAP. It did not assess the
implementation of other goals in the NAP.
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On the other hand, the convenient non-probability sampling of the respondents to the
questionnaire does not guarantee a representative random sampling; therefore, it may not represent
the whole population accurately. In addition, almost two-thirds of the respondents to the survey
were of medical background, and more than 90% were from urban areas, which may not reflect
the actual population in Egypt.

3.2.6 Delimitation of the research
Further research is required to assess the implementation of other NAP goals to reach the
ultimate impact. Additionally, an in-depth analysis of the Egyptians' knowledge, attitudes, and
practices on antimicrobial resistance and antibiotic use is required in each human, agriculture, and
environment sector. This analysis shall be done using a random sampling technique to allow the
generalization of the results. Moreover, covering more geographical areas will be of greater
interest, mainly suburban and rural areas of Egypt.
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Chapter 4: Results
4.1 Interviews results
4.1.1 One Health
One Health's main theme is the participation of human, animal, and environmental health
in developing and implementing the NAP. When it comes to implementation, there is a multirepresentation of the tripartite in a higher ministerial-level meeting. Several governmental entities
were included such as MoHP, the Ministry of Agriculture, the General Organization for the
Veterinary Sector (GOVS), the Ministry of Environment (MoEnv), the Ministry of Higher
Education (MoHE), the Ministry of Finance, the Egyptian Drug Authority (EDA), and the
Universal Health Coverage Authority (UHC). The WHO and FAO were also included. This
meeting was held in late 2021 to reactivate the NAP after being deactivated because of the COVID19 pandemic that shifted all the resources and efforts allocated for the NAP to the containment of
the pandemic as informed by the interview respondent. A primary step in the implementation, is
allocating the AMR folder to the pre-existent committee for endemic diseases and avian flu under
the prime minister's direct supervision. This committee is renamed the National Committee for
Endemic Diseases, Avian Flu, and AMR. It includes representatives from different stakeholders
and reports directly to the prime minister as mentioned by the interview respondent.

4.1.2 Policy design
The policy design theme was further subdivided into five main sub-themes: strategic
vision, coordination, participation, accountability, and transparency.
For the NAP's strategic vision, it was found that there is a NAP developed in Egypt for the
AMR for four years between 2018 and 2022. It has four strategic goals, each goal has to be reached
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via several strategic objectives, and each objective has to be achieved by a set of activities
elaborated in an operational plan for each objective. The operational plan is time-bound and
measurable, defining the responsible entity for each activity. There has also been a monitoring and
evaluation plan to monitor and evaluate the plan's progress. The minister of health authorized the
NAP in March 2019. However, because of COVID, most resources were shifted toward the crisis.
Therefore, the NAP became deactivated as declared by one of the interview respondents. There
has not been a re-evaluation for the NAP after COVID; consequently, each stakeholder has to work
again on the NAP as per one of the interviewees` comments.

There has been coordination between all relevant sectors since the NAP development,
where multiple stakeholders have participated in the NAP development. Those stakeholders
include the Ministry of Health and Population, the Ministry of Agriculture, the Ministry of
Environment, the Ministry of Higher Education, the Ministry of Education, the Ministry of
Interior, the WHO Egypt Office, the FAO Egypt Office, the pharmaceutical industry, and the
supreme council of universities including representatives from Ain Shams and Cairo universities.
There were representatives from the faculty of medicines, faculty of pharmacy, faculty of
veterinary medicine, and faculty of agriculture. (Egypt National Action Plan For Antimicrobial
Resistance, 2018).

By the end of 2021, the WHO and the FAO initiated a reactivation of the NAP governance.
Several consecutive meetings targeted the NAP stakeholders in addition to the presidential
assistant on health, a representative from the international collaboration entity, and a representative
from the Ministry of External Affairs. It aimed to establish a higher-level committee directly
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reporting to the Prime Minister, as one of the interviewees mentioned. This step was crucial for
re-initiating the NAP governance mechanism that was not initiated because of COVID, where it
was planned to establish four technical working groups (TWG) for the four goals of the NAP and
a fifth one for the financial support. Each TWG should consist of a representative from each
concerned stakeholder for implementing each goal, as shown in figure (3) below, which describes
the governance mechanism of the Egyptian NAP.

Figure (3.a): The governance structure of the Egyptian NAP for AMR

NAP AMR committee
Communication
technical working group

Antimicrobial
stewardship technical
working group

Surveillance technical
working group

IPC technical working
group

Fund Raising technical
working group

Source: Adapted from “Egypt National Action Plan For Antimicrobial Resistance (2018)
For human health, there is a recently established committee for antibiotic stewardship to
steer the ongoing coordination among different sectors such as MoHP, EDA, the unified
purchasing authority (UPA), and the Universal Health Coverage Authority (UHC) in 2022. This
coordination is for establishing stewardship programs in public sector hospitals to control the use
of antibiotics in hospitals as mentioned by one of the interview respondents. While for animal
health, there has been recent coordination in the form of academic research between the FAO and
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the faculties of veterinary medicines on AMR surveillance in animals, as informed by one of the
interviewees.

The NAP included a brief description of its governance mechanism that described the roles
and responsibilities of each stakeholder, and set the accountability process through the formation
of a higher committee that supervises five subordinate TWGs for the implementation of the four
identified goals as well as raising funds for the NAP (Egypt National Action Plan For
Antimicrobial Resistance, 2018). The NAP higher committee is not recently established. It was a
previously set committee for endemic and avian flu. After the meetings held in December 2022 by
the WHO, it became known as the national committee for endemic diseases, avian flu, and AMR.
This committee is under the direct supervision of the Prime Minister as mentioned by one of the
interview respondents. For human health, one of the interview respondents informed that there has
been the recently established committee for antibiotic stewardship that included a nominated focal
point representative for each stakeholder. In contrast, for animal health, there has been an
independent committee for conducting KAP studies for users targeting dairy animals (poultry and
large animals). Recently in 2022, a focal person in each administration in the General Authority
for Veterinary Services (GOVS) has been assigned to monitor the implementation of the NAP
activities in the animal health sector as said by another interview respondent.

Finally, for the transparency sub-section in the policy design of the NAP, it was found that
the NAP was not publicly available on the official websites of the government; yet, it is published
on the WHO website. Similarly, reports on antibiotic use, consumption, and antimicrobial
resistance patterns are publicly available on the WHO platform. Moreover, owing to the
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deactivation state of the NAP, there are no progress reports publicly available for the NAP
activities. Almost no activities have been done except for some infection prevention and control
(IPC) practices and antibiotic stewardship programs (ASPs).

(Prime minister
Supervision)

Higher committee
for endimic, avian
flu and AMR

Human Health
committee

ASP committee
(EDA)

GOVS committee

Independent
committee

IPC committee
(MoHP)

Figure (3.b): The governance structure of the Egyptian NAP for AMR
Source: Author's conclusions from the findings of interviews

4.1.3 Implementation
The implementation theme was divided into three sub-themes: Education, public
awareness, HCPs' awareness of antimicrobial stewardship programs, and infection and prevention
control practices.
The continuous professional development provided by both; the MoHP and EDA has
included pieces of training on AMR within the continuous training on IPC by the MoHP, and ASP
by the EDA. These pieces of training are mandatory for physicians for their professional promotion
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within the MoHP. In comparison, pieces of training provided by the EDA are not mandatory for
pharmacists. Nevertheless, the EDA rewards the best projects implemented on ASP as published
in Al-Shrouk newspaper on the 17th of July 2022 (Shrouk, 17 July 2021). Moreover, MoHP and
EDA have released guidelines for best practices of IPC and some Antimicrobial Stewardship
Program (ASP) activities. However, these guidelines are not obligatory for healthcare institutions
as mentioned by a respondent within the interview. In addition, the health care authority, which is
affiliated with the Universal Health Coverage Authority, organized scientific conferences for
healthcare providers as announced on the public newspaper Al-Ahram gate on the 17th of May,
2022 (Ahram-gate, 17 May, 2022). The animal health sector lacks such activities for healthcare
providers, except for some scientific conferences that are held from time to time as mentioned by
one interviewee during the interview.

Regarding the academic curricula of the medical schools, it was found that some pharmacy,
medicine, and veterinary medicine schools have included the AMR topic and prudent use of
antibiotics in the undergraduate curriculum (WHO, 2021b). Additionally, a university professor
noted during an interview with the researcher that post-graduate students are encouraged to tackle
the AMR area in their research, whether in animal or human health as mentioned by one respondent
during the interview.

For public awareness, some initiatives were raised to increase the public awareness of
AMR in the last year conducted by the MoHP and the EDA as noted by one of the interview
respondents during an interview with the researcher. For instance, the EDA has participated in the
world antibiotic awareness week. In November 2021, it went blue like everywhere in the world as
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per the CDC initiative. This activity is within the EDA's role in increasing public awareness of
AMR and how to combat it (EDA, 2021). Secondly, the EDA sometimes releases messages to the
public via a public newspaper to warn them against the misuse of antibiotics and the threat it
imposes on public health due to the overuse of antibiotics as published in Veto gate newspaper.
(Veto-gate, 20 November 2021).

It is worth mentioning that the pandemic paved the way for the IPC working group to
improve public awareness of the importance of vaccination against COVID and other diseases in
general, as well as promoting the best hygiene practices such as washing hands regularly. These
messages targeted all Egyptians through different means of communication such as television,
street advertising, radio, and newspaper. These topics were included in the NAP activities to
increase public awareness of the importance of vaccination and infection prevention practices.
However, these activities were meant to be conducted in general for routine vaccination programs
for human, animal, and agriculture sectors rather than COVID specific as informed by one of the
interview respondents.

In contrast to human and animal health, there is lack of initiatives to raise the awareness of
AMR in the plant health as indicated in the country’s self-assessment tool on AMR progress, the
TrACSS platform (WHO, 2021c).

4.1.4 Monitoring and evaluation
The monitoring and evaluation theme was subdivided into reporting, feedback, and
effectiveness evaluation. The NAP has developed a monitoring and evaluation plan for the
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implementation and follow-up of its activities. However, no monitoring and evaluation activities
were conducted owing to the COVID-19 pandemic that deactivated the NAP. There were neither
annual surveillance reports published containing data on the AMR and AMU nor any regular
feedback on the progress of the NAP. Subsequently, there were no efforts to measure the
effectiveness of the NAP and the cost-benefit evaluation because the NAP implementation has just
started, as mentioned by some interviewees. One of the interview respondents mentioned that such
processes should be on the national level in the future. However, at the hospital level, there are
some minor activities to measure the cost-effectiveness of the ASP implementation within the
EDA initiative to promote the rational use of antibiotics. Additionally, the Egyptian government
used to report the annual data on AMR and antimicrobial consumption (AMC) on the WHO Global
Antimicrobial Resistance and Use Surveillance System (GLASS) platform.

4.1.5 Sustainability
The sustainability theme was subdivided into a mandate for implementation, a dedicated
budget, and an advisory group for technical implementation, monitoring, and evaluation subthemes.
All interviewees denied having any agreements regarding what happens if objectives are
not met. They all mentioned that such activities are done as an extra task in their organization's
work, and it was not mandatory up till the interviews were conducted. Even though the NAP has
set an estimated budget for each objective, the fundraising TWG has not been developed. However,
some activities have a dedicated budget for activities implementation. For example, the pilot KAP
studies of users and veterinarians for animal health, as well as some IPC activities in the public
hospitals for human health, as mentioned by two of the interview respondents during the interviews
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with them. On the other hand, some multinational pharmaceutical companies set a dedicated
budget for raising awareness among healthcare providers, including physicians, pharmacists, and
nurses, on AMR and promoting best practices. However, this is not controlled by the government
at all. However, it follows the pharmaceutical company's political agenda on the global level, as
noted by one of the interviewees during the interview.

Another aspect of sustainability is the availability of a technical advisory group that
supports filling the gaps and continuously monitors and evaluates the NAP progress. One of the
interviewees mentioned that: “…Global NGOs representatives are included within each TWG to
support implementation, monitoring and evaluation. But this was delayed because of COVID
where all resources were shifted to the pandemic…”. Another interviewee mentioned that the
GOVS organization has ongoing activities to advise the farmers to use pesticides better. However,
these activities are independent of the NAP as no task force was formed for the NAP
implementation in animal health. During the interview, one respondent mentioned that in June
2022, there were nominated AMR focal points for each administration at the GOVS, and they will
work on interconnecting these activities in favor of NAP implementation. In human health, some
technical experts provide technical support for the hospitals in implementing the IPC practices by
the MoHP, and others for ASP initiatives and rational antimicrobial use by the EDA as mentioned
by a respondent during the interview with him/her.

4.2 Survey results
A descriptive analysis was conducted using the statistical software IBM SPSS version 22,
and Microsoft Excel professional plus 2016 was used for the graphical representation of the
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analysis. Further stratification of the gathered information is done based on the educational
background. Those with medical backgrounds and practitioners shall have more opportunities to
increase their awareness of AMR through scientific journals and continuous educational programs
and conferences.

4.2.1 Demographics of respondents
The survey was available from
November 2021 to March 2022, with a
total number of 567 respondents.

Geographical distribution of the
respondents
28, 6%

18, 3%

There were 495 respondents who fulfilled
the inclusion criteria of the survey; who
live in Egypt and are above 18 years old.
Slightly more than three-quarters of them
449, 91%

were females (77.5%). Half of the
Urban

Sub-urban

Rural

respondents live in Cairo, while one-fifth
of them (19.7%) live in Giza. Those who

Figure (4): Geographical areas
distribution of respondents

live in urban areas represented the vast
majority of the respondents by 90.7%, as illustrated in the Pie chart figure (4). Slightly more than
three-quarters of the respondents were females (77.6%). Three-fifths of the respondents have a
bachelor's degree or equivalent, and one-third have post-graduate degrees; either a master's or a
doctoral degree.
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less than half of them (47.4%)
are within the age group from 25
to 34 years old, followed by twothirds of them from 35 to 44
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55-64
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18 15
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35-44

125

25-34
25-34
18-24

163

18-24

47
47

125

72
72

163
9 12

9 12

NUMBER OF RESPONDENTS

years old (34.7%), as shown in
Figure (5): The age group of respondents with a medical
and non-medical background.

the graph in figure (5).

4.2.2 Use of antibiotics among respondents
This sub-section shows
the

frequency

of
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Figure (6): Frequency of Antibiotic Use.

with medical and non-medical backgrounds did not vary (Figure 6).

57

Most respondents bought their antibiotics from a pharmacy (95%). At the same time, the
others took them from a friend/family member, or were saved up from a previous time, or cannot
remember. More than two-thirds of the respondents got their antibiotics based on a doctor's or a
pharmacist's advice, while only 18% used them on their own (Figure 7). Regarding directions on
the use and following the antibiotic course regimen, only 16% of the respondents did not receive
any advice on the proper use of antibiotics. At the same time, four-fifths of them got information
on the directions of use (Figure 8).
Prescription of Can`t
Antibiotic
by specialist
specialist
antibiotic by
remember
21, 4%

Can`t antibiotic use
Advice on proper
remember
4%

No
16%

87,No
18%
18%

379,
Yes 78%
78%
Yes

No

Can`t remember

Figure (7): Prescription of antibiotics by
a specialist.

Yes
80%
Yes

No

Can`t remember

Figure (8): Advice on proper antibiotic use.

These findings disclose that more than two-thirds of the respondents have the knowledge
of the use of antibiotics properly as directed by the specialist. Very few of them got their antibiotic
from sources other than the pharmacy. These two pieces of information reflect the role of doctors
and pharmacists as essential sources of information on when and how to use antibiotics.
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4.2.3 Knowledge on antibiotics
This sub-section shows different levels of knowledge on the appropriate use of antibiotics,
such as the antibiotic's indication and perception of its use. Most of the respondents have the right
(or adequate) knowledge that antibiotics were used to treat urinary bladder and skin/wound
infections, with 78% and 60% answering right, respectively. However, more than half of them
(56.6%) think mistakenly that antibiotics were used to treat sore throats. Additionally, few think
(mistakenly) that antibiotics are used to treat viral infections such as HIV/AIDS, measles, and
cold/flu (2%, 4%, and 21%; respectively). On the other hand, only 22% know that gonorrhea is
treatable with antibiotics. This information reveals gaps in the indications for antibiotic use and
misuse. The percentage of difference in responses did not vary much between those with a medical
background or not. Both have some right/appropriate information on the indication of antibiotics
to treat some diseases, and some false/incorrect information on antibiotics are not indicated for
some diseases or antibiotics should be indicated for other diseases.

The perception of the respondents on

Perception on Antibiotic cessation when
indicated

those with medical backgrounds or non
medical backgrounds. More than four-fifths
of the respondents understand that they
should stop antibiotic use after the course
completion as prescribed by the specialist
physicians. In contrast, slightly more than
one-tenth (11%) of those with non medical

% of respondents

the use of antibiotics slightly varies between

95.60%
89.03%

100.00%
80.00%
60.00%
40.00%
20.00%

4.09%10.32%

0.31% 0.65%

0.00%
When I feen
better

As directed

I donot know

Perceptions of medical and non medical background
respondents
Med.

Non. Med.

Figure (9): Perception of Antibiotic cessation
when indicated among medical and non-medical
background
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backgrounds do not know this information compared to 4% of respondents with a medical
background, as shown in Figure 9.

The correct perception of the respondents on the possibility of reusing the same antibiotic
used previously for the same illness
Perception on antibiotic reuse
(Figure 10) is higher among those

those with non medical backgrounds

% of respondents

with medical backgrounds than

93.40%
85.16%

100.00%
80.00%
60.00%
40.00%
20.00%

(93% versus 85%, respectively).

5.97% 8.39%

0.00%
TRUE

These findings reveal that
despite the respondents' overall high
awareness of antibiotics use, those

0.63% 6.45%
FALSE

Do not know

It is ok to use the antibiotic used before for the same illness
Med

Non. Med

Figure (10): Perception of antibiotic reuse

with non-medical backgrounds have less knowledge compared to those with medical backgrounds
on the attitude towards the use of antibiotics.
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4.2.4 Knowledge about antimicrobial resistance
This sub-section investigates to what extent the respondents are familiar with the key terms
of antimicrobial resistance that the NAP was developed to combat. More than 90% of the
respondents are aware of the

Awareness of key terms related to
antibiotic resistance

term "Antibiotic resistance",
three quarters are aware of the

Superbugs

136

antibiotic

"Resistance

bacteria", and slightly more
than two-thirds of them are
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175

Antimicrobial resistance
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311

Antibiotic resistance

375
0

aware of the terms "Drug
resistance” and “Antimicrobial
resistance figure (11). The
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Figure (11): Awareness of key terms related to
antibiotic resistance

abbreviation of antimicrobial resistance "AMR" is familiar to 42% of the respondents, while the
term "Superbugs" is known to only one-third of the respondents. Some of those who are familiar
with the term "Antibiotic resistance" are not fully aware of its meaning. For instance, two-thirds
of the respondents (66%) think (mistakenly) that antibiotic resistance occurs when their bodies do
not respond to the antibiotics, and subsequently, they no longer work. Moreover, few of them (8%)
think that antibiotic resistance is not an issue in Egypt but in other countries. Moreover, a quarter
of them (25%) think that antibiotic resistance concerns those who regularly take antibiotics, and
one-third think resistant bacteria cannot be spread among individuals. On the other hand, the
majority of the respondents think somewhat correctly that many infections are becoming resistant
to antibiotics treatment in an ascending manner, and that infections by resistant bacteria could
make medical procedures relatively more dangerous (92% and 90%, respectively).
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Figure (12): AMR terms sources of information
respectively),

as

shown in Figure (12).
These results reflect that although many of the respondents are familiar with the terms
related to antibiotic resistance, some do not have the correct information.

4.2.5 Knowledge of antibiotics use in agriculture
This sub-section assesses the respondents'
perception of the use of antibiotics in agriculture.
Two-thirds

of

the

respondents

Awareness on the wide use of
antibiotic in Agriculture
Do not
know
34%

think

antibiotics are widely used in agriculture, as shown

Yes
63%

No
3%

in figure (13). Additionally, more than four-fifths
Yes

No

Do not know

(84.6%) of the respondents agree that farmers should
use fewer antibiotics in agriculture. Because farmers

Figure (13): Awareness of the wide
use of antibiotics in Agriculture

usually use antibiotics in animal feed for growth promotion (Larson, 2007).
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4.2.6 Expectations from the government
When the respondents were asked about their evaluation of the Egyptian NAP governance
activities, the overall evaluation was average to the time of NAP development. However, it was

Average score

Average score on NAP evaluation on a scale from 1 to 10
10
9
8
7
6
5
4
3
2
1
0

Timely
Include appropriate level of
stakeholder involvement.

5.36
4.55

4.64

4.33

4.04

lead to practical solutions

3.29

Well written and easy to understand
Adequately disseminated

Evaluation item

Figure (14): Average score on NAP evaluation on a scale from 1 to 10
below average in terms of including the appropriate level of stakeholders, leading to practical
solutions, well written and easily understood, disseminated adequately, and adaptable to Egypt's
specific challenges and circumstances (see Figure 14).
These findings reflect the below-average evaluation of the respondents to the governance
of the NAP in Egypt.
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4.2.7 Means of communication and information dissemination
When respondents were asked to mention the means used for gaining information and their
preferred way of having it, it was found that internet surfing and social media were the most
common sources of information used by the respondents to be aware of the AMR. They
represented 65% and 34%, respectively. On the other hand, local radio, newspaper, and television
were rarely used to have information on AMR and represented 1.6%, 3.94%, and 6.76%,
respectively, as shown in the Figure (15) below.
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17.75%
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13.24%
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16.90%

6.47%
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used to have

65.35%
59.15%

Mean s o f c o mmu n i cat i o n

Communication means respondents used to have information versus their preferred to have

Figure (15): Means of having information on AMR
On the contrary, when they were asked to mention the preferred way to have any
information on the AMR, the percentage of local television and local radio as means of having
information leaped to 27% and 17%, respectively. In the same pattern, social media as a preferred
information source also increased to 50%. However, internet surfing as a preferred way of having
information on AMR slightly decreased to 59%.
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Chapter 5: Discussions and Analyses
5.1 Governance of AMR
The findings of the study reveal that the Egyptian NAP development is vertically
aligned with the GAP in the first four goals: improving public awareness of AMR, enhancing
AMR surveillance, encouraging infection and prevention control practices, and optimizing
antimicrobials use. However, it did not tackle the fifth objective, promoting research and
investment in the field. Maybe this is due to the lack of the required resources for research and
investment in the pharmaceutical field, as mentioned in the situational analysis of the NAP (Egypt
National Action Plan for Antimicrobial Resistance, 2018). On the other hand, when it comes to
the horizontal alignment with the global goals, the NAP implementation did not show a
pronounced horizontal alignment in accordance with the global preferences except for some nonsubstantial activities conducted in an un-coordinated manner in the human health sector. That is
elaborated in the implementation domain of the governance framework below.
Moreover, an isomorphic mimicry behavior in the NAP implementation was noticed,
which would be discussed in each area below. Isomorphic mimicry is one of the critical issues that
evolves during NAP implementation as discussed in the literature (Munkholm & Rubin, 2020;
Rubin & Munkholm, 2021; Saleem et al., 2022).

5.2 One Health
The results showed that the NAP integrated all relevant stakeholders successfully in the
NAP development. The NAP included the participation of representatives from human, animal,
and environment health, and the higher political support of the prime minister like most NAPs
developed. Nonetheless, the environment sector is non-functioning at all and environmental health
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activities are entirely missed concerning any NAP activity. While the animal sector has just
initiated some of the NAP activities, which are conducting KAP studies, and AMR surveillance
studies in animals. Only Human health showed some implemented and ongoing activities related
to the NAP. However, these activities are not generalized and are not performed in a collaborating
manner as recommended by the tripartite organizations. These activities are recognized as a
detachment from the horizontal alignment to the global goals, which is found in many countries
implementing their NAPs (Munkholm et al., 2021; Rubin & Munkholm, 2021; Ryan, 2021; WHO
et al., 2022). To conclude, the isomorphic mimicry attitude is manifested in the NAP as a
discordance between the NAP development and implementation. The lack of collaboration among
different sectors and the absence of any activity related to environmental health reveal that mimicry
pattern. This drawback is manifested in multiple literature as discussed by (Orubu, et al., 2020;
Nair, et al., 2021).

5.3 Policy design
Multiple NAPs suffer from an isomorphism behavior during their implementation as
discussed by Rubin and Munkholm, (2021). An isomorphic mimicry approach has been noticed
between the NAP development and implementation in the policy design as well. The governance
mechanism developed by the NAP was not perfectly implemented as described. As elaborated in
the findings, the governance framework that was described in the Egyptian NAP (Egypt National
Action Plan For Antimicrobial Resistance, 2018, p.26) was different from what is actually going
on. Not all the TWGs were developed, and not all the developed TWGs are functioning as
prescribed in the NAP. Eventually, the Egyptian NAP policy design showed some strengths and
weaknesses.
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The developed NAP has already embraced most of the dimensions of a successful policy
design. Such as a strategic vision with clear goals and targets based on a local situational analysis
done by all stakeholders of One Health. Additionally, it has defined the responsible supreme
committee to follow up and oversight the implementation of the NAP across the country. To
elaborate, it has clearly described the governance mechanism of the NAP, where it defined the
centralized, hierarchical approach that the supreme national steering committee leads. From this,
five TWGs are subordinated to be responsible for implementing each goal in the NAP.
Additionally, the NAP also described the responsible party or parties corresponding to each
activity in the operational plans of the NAP, which reflected the accountability of the policy design.
Accountability of NAP`s activities is crucial to diminish the implementation gap as argued by
Harant (2022). Moreover, it has defined smart objectives with an operational plan bound to a
timeline. However, these items were hardly implemented, reflecting the isomimicry approach.

On the other hand, the policy design of the NAP missed some vital approaches for a
comprehensive policy design. For instance, the NAP was not legally bound to any legislation or
regulation in the country. Legally bound NAPs are more effective and sustainable than those that
are not legally bound (Munkholm & Rubin, 2020; Rubin & Munkholm, 2021; WHO, 2008).
Moreover, it did not explain how transparency can be applied within the NAP development.
Having a transparent and accountable system paves the way for a sustainable and efficient
implementation of NAPs goals (Chua et al., 2021; Frumence et al., 2021; Siddiqi et al., 2009;
Sitienei et al., 2018). Additionally, there was no evidence describing how the harmonized
collaboration and reporting among One Health stakeholders can be implemented, which led to an
implementation gap, as what was discussed earlier by Harant (2022). Lastly, it did not elaborate
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on how resources reallocation could occur, not only the financial ones but also the human and
infrastructure resources. Budgeting and resources allocation are very important topics to be
strongly considered by policy makers to guarantee the sustainability and the success of their plans
(Ahmed & Naher, 2022; Harant, 2022; Lewis & Pettersson, 2009; Röing, et al., 2020).

5.4 Implementation
For the first goal of the NAP, despite multiple isomorphic mimicry behaviors between the
development and implementation, and the previously set timeframe, the human health sector made
the most significant efforts toward that goal. These efforts were conducted by the EDA and the
MoHP, which targeted raising public awareness and HCPs' education.
The human health sector has conducted some national awareness-raising initiatives for
public awareness. The EDA turned blue in the WAAW 2021, EDA posted some insights on the
AMR and appropriate antibiotics use on the official Facebook page. The MoHP similarly posted
some guidance on the AMR and IPC practices among the community. Fortunately, because of
COVID, the MoHP conducted a vast media campaign on the importance of COVID vaccination
and proper hygienic practice through local television and radio. However, it is noticed that both
parties used only the official Facebooks pages for direct awareness of AMR and its topics. The
only conducted media campaign was for COVID vaccination. It did not include the routine
vaccinations for human and animals, unlike what was mentioned in the NAP. It may be owing to
the emergence of COVID and resources shifting toward the pandemic. Such activities on raising
public awareness are widely implemented in multiple countries to increase public awareness
(Jimah & Ogunseitan, 2020; WHO et al., 2022).
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The EDA and MoHP made reasonable efforts to educate healthcare providers in different
sectors. The MoHP has successfully implemented IPC prerequisite pieces of training for the career
promotions of physicians working in public hospitals. Nevertheless, the EDA has initiated
educational training projects on ASP for pharmacists working in public hospitals to promote the
rational use of antimicrobials in healthcare settings. EDA has evaluated the implemented projects
in hospitals and eventually rewarded and appreciated the best projects implemented. The animal
health sector has recently initiated KAP studies, but no results have yet appeared. These activities
for educating HCPs and rewarding the best achievers are unusual, yet very important activities to
motivate HCP on having knowledge on AMR (Abdelaziz et al., 2019; Blunt, 2016; Greer, et al.,
2012).

On the other hand, one of the interview respondents declared that because of COVID, many
activities mentioned in the NAP to raise public awareness were not implemented, leading to a
deactivation status. Such as: developing a communication TWG responsible for creating a public
communication plan and evaluating these campaigns. Moreover, it was planned to integrate the
AMR topic into the children's school curricula in collaboration with the MoE, and as a prerequisite
for postgraduates in the agriculture and environment colleges, in collaboration with the MoHE.
Moreover, it was planned to conduct KAP studies, baseline assessment surveys among citizens
and HCPs, and capacity-building workshops for implementing the awareness programs.
Likewise, most NAPs developed, the Egyptian NAP showed a conspicuous absence of the
environment sector in the NAP implementation. This is one of the most commonly identified gaps
in NAPs implementation (Ahmed & Naher, 2022; Orubu et al., 2020; Munkholm et al., 2021;
Saleem et al., 2022).
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5.5 Monitoring and evaluation
There were no reporting and feedback mechanisms described in the Egyptian NAP. It is
noticed that despite the non-substantial activities of the NAP in human health, there were no
generated reports shared among the different entities, the EDA and the MoHP, nor shared with the
public. Harant (2022) argued for publishing reports on NAP progress on governmental websites
to the public to gain their support in curbing the AMR. Regarding the existence of the supreme
national committee, its role was restricted to follow-up and supervising the implementation of
activities. However, it lacked any agreements or mandates to enforce reporting and feedback
among stakeholders, which is a significant drawback in the policy design of the NAP. It will
eventually lead to the fragmentation of the process, unlike what is aimed for globally, the
harmonization and collaboration among relevant sectors (Harant, 2022; Rubin & Munkholm,
2021, WHO et al., 2022) . Moreover, no evidence supports the dissemination of the NAP on the
national level.

The evaluation of the implemented activities in Human health is restricted to some piloted
local level hospitals, where the EDA concerned unit evaluates hospitals' projects on antimicrobial
stewardship programs for rational drug use. The best achievers are rewarded and appreciated by
the EDA. This activity is a step forward toward good governance. Despite the limited evaluation
processes, this practice has to be generalized across all sectors and levels to help share success
stories and best practices among practitioners. According to Tashobya et al. (2014), creating a
competitive environment among hospitals and benchmarking improve the outcomes and support
the sustainability of the governance mechanism. It is worth mentioning that competitions and
benchmarking should not only be restricted to the local level. It should be across different sectors
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and levels in the country and nations. (Orubu et al., 2020; Joshi et al., 2021). The TrACSS platform
allows the benchmarking of countries based on their annual self-assessment questionnaire,
including their activities in raising public awareness (WHO, 2021b).

5.6 Sustainability
Egypt has set in its NAP for AMR the monetary values for implementing the required
activities; however, there was no description of the source of funding (Egypt National Action Plan
for Antimicrobial Resistance, 2018). In addition, as mentioned in the TrACSS platform (WHO,
2021b), Egypt did not bind the implementation of NAP's activities to any ongoing national
program. Moreover, having a non-established TWG for fundraising also reflects an isomorphism
mimicry. Lastly, the NAP stakeholders' denials of having any agreement or mandate on
implementing the NAP's activities hinder the sustainability of the NAP.

On the other hand, concerning working on gaps and challenges identified to guarantee the
NAP's sustainability, the Egyptian NAP has been re-activated after years of deactivation, because
of COVID. However, there are some gaps found that may affect sustainability negatively as
discussed in multiple literature (Anderson et al., 2019; Chua et al., 2021). First, the lack of written
agreements or mandates supporting the NAP implementation across different settings. Second the
unavailability of a well-established funding resource. Third, the unbinding of NAP activities to
legislation and national regulations.
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5.7 Public awareness
Like most countries conducted the survey, most of the respondents reported that they had
used antibiotics in the past six months and reported that they were given instructions on how to
use the antibiotics from the pharmacist or the prescribers (Prigitano et al., 2018; WHO, 2015).
Regarding the knowledge of antibiotics, despite most of the respondents having the proper
knowledge on when to stop taking antibiotics and that they should not reuse the same antibiotics
for treating the same illness, they do not know all of the proper indications of the antibiotics. They
need to have more knowledge on the use of antibiotics in agriculture. These findings align with
those in lower-income countries as per the WHO report in 2015 (WHO, 2015).

The knowledge of AMR and its terms was less pronounced than the knowledge of
antibiotics. Additionally, those who were aware of the terms did not fully understand the meaning,
and most of them agreed that they had heard about them from medical experts and scientific
articles. This finding reflects the substantial role of medical experts, pharmacists, and doctors in
providing information to the public. These findings are consistent with the WHO and other
countries` findings such as Bangladesh and India (Orubu et al., 2020; Kotwani, et al., 2021; Nair
et al., 2021; WHO, 2015).

For the public's evaluation of the government performance in the AMR issue, the overall
evaluation was slightly below the average, most probably because they were unaware of the
existence of the NAP, and it was neither adequately disseminated nor publicly available. This
finding reflects the importance of transparency and communication with the public on AMR to
help their behavioral change towards the issue. Having discussed the public's awareness of AMR
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and their evaluation of the government's actions towards the issue, it is necessary to discuss the
channels of communicating the information to the Egyptians.

Internet surfing and social media are the most commonly used channels for information
and the most preferred ways too. The findings further revealed that local communication channels
such as TV, radio, and newspaper were of higher interest to the Egyptians than the government
expects. Therefore, it should be considered by the government to share information and reports
more frequently than it was used. O'Neil (2016) recommended these means in his AMR report to
raise public awareness of AMR. Furthermore, it was recommended to use periodicals as channels
for raising awareness of AMR more frequently.
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Chapter 6: Conclusions and recommendations
This research aims to understand the governance of the NAP`s implementation for raising
public awareness on AMR, and identify areas for improvement in the implementation. Enhancing
AMR awareness paves the way for more straightforward implementation of other NAP goals and
better containment of the AMR crisis across Egypt, the region, and the whole world.

The governance mechanism of the Egyptian NAP for AMR is well developed. Yet, like
many other countries, there are some difficulties in the implementation of its activities. Egypt has
developed a comprehensive NAP including all stakeholders for the period from 2018 to 2022. The
NAP is vertically aligned with the GAP except for the fifth goal, investment, and research in the
AMR, and it is based on the situational analysis conducted during the NAP development. However,
due to COVID-19, and few governance gaps, some challenges in the implementation of the NAP
led to an isomorphic mimicry behavior between the NAP development and its implementation
concerning the five domains of the governance framework adopted; the NAP policy design, the
NAP implementation, the monitoring and evaluation, the sustainability, and the One Health
approach.

When it comes to the policy design of the NAP, it was found that the Egyptian NAP`s four
goals were consistent with the GAP first four goals, including raising public awareness on AMR.
The Egyptian NAP policy design has set clear vision and defined the first goal to raise public
awareness and educate HCPs for the containment of AMR in Egypt. Moreover, it defined an
accountable system for raising public awareness and continuously educating HCPs on it. Which is
the TWG for raising public awareness on AMR that is subordinated from the central supreme
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national committee for AMR. However, the policy design did not bind this mechanism to any legal
mandate or existing regulations. Additionally, it did not define a clear mechanism for transparency
and collaboration among different sectors of One Health.

For the implementation of raising public awareness and educating HCPs on AMR. As
mentioned in the policy design, there was a dedicated TWG for raising public awareness and
educating HCPs on AMR. However, this TWG was not constituted. Which demonstrated an
isomorphic mimicry state. Instead, the human health sector, represented in the MoHP and the
EDA, conducted some awareness activities to the public and HCPs. These activities were done
independently, without any collaboration or previous agreement between the two entities. Both the
Animal and environment health sectors lacked any activity for raising public awareness. It was
observed that the stakeholders did not conduct any baseline survey assessing the knowledge,
practice, and attitude of the public on AMR and its terms.

On the other hand, by assessing the public awareness on AMR and AMU, many
respondents were aware of the right indications for the antibiotics, and that they have to follow the
experts` advice on the course regimen. Moreover, some respondents were aware of the AMR
terms, but many of them did not understand the true meaning of them. Additionally, more than
two-thirds of them were knowledgeable about the limitation of antibiotic use in agriculture.

While the most common sources of information on AMR were from the scientific
literature, the pharmacists, and the doctors, in order. The survey respondents showed great interest
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in having such information on AMR via social media and the internet. There were also reasonable
preferences on having information through local television and local radio stations.

For the evaluation and monitoring of the NAP activities on raising public awareness.
Despite the lack of a governing TWG for implementing and evaluating the NAP activities, the
EDA did pronounced efforts on evaluating the HCPs` performance on antimicrobial stewardship
in some public hospitals. However, evaluating the public awareness on AMR was not considered
by any entity included in the NAP. The public evaluation on the government performance was
slightly below average, as they found that the NAP was not adequately disseminated to them, and
was not publicly available. More than half of them were unaware of the NAP existence.

For the sustainability of the NAP, the NAP has set the monetary values required for each
NAP activity; yet, it did not define the source of funding, neither bind the activities to any existent
public health program. Moreover, the fundraising TWG was not established. Therefore, the
sustainability of the NAP is not guaranteed as long as there is no available defined source of
funding, and no resources reallocation is done.

For the One Health approach, the Egyptian NAP succeeded in the integration of all One
Health sectors; human, animal, and environment, in the NAP development; however, like many
other countries, it struggled in harmonizing the collaborative activities of the One Health approach
in raising public awareness. Only the human health sector did some independent activities on
raising public awareness and educating HCPs on AMR. Both animal and environment sectors did
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not have any role in raising the public awareness on AMR. Yet, the animal sector did few activities
for educating HCPs on AMR.

From the above mentioned conclusions, several challenges were identified in the
governance mechanism of the NAP implementation for raising public awareness and educating
HCPs on AMR. Firstly, the lack of enforcement of One Health collaboration in implementing the
NAP through the absence of the environment health activities. Secondly, the lack of legal
provisions mandating the NAP implementation in different sectors. Thirdly, the lack of reporting
system to promote the accountability and transparency of NAP stakeholders. Fourthly, the weak
sustainability triggers within the policy design of the NAP. Fifthly, the unavailability of any public
awareness survey to understand the knowledge gaps of the public and HCPs.

Therefore, after assessing the Egyptian NAP's governance mechanism (2018-2022) and
examining the public awareness of the AMR, there are some recommendations for the NAP
developers to consider while re-issuing the NAP for the coming years concerning the governance
mechanism and raising public awareness.
1- The One Health stakeholders have to work in a more collaborating and harmonizing
manner at all levels, in addition to activating the environment sector to work on the AMR
issue.
2- The supreme national committee for AMR in Egypt should consider binding the NAP
legally and enforcing regulations on antimicrobial use in different sectors. Additionally, it
should consider transparency in all sectors at all levels. Moreover, it should clearly define
the resources required for the NAP implementation; human, financial, and infrastructure.
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3- There should be a well-developed reporting mechanism to monitor and follow up on the
implementation at all levels and across different sectors. Performance evaluation and
feedback are recommended to all concerned stakeholders, including the public. The public
has to be aware of the progress of the NAP as part of the community behavioral change
toward the AMR. In addition, creating a national benchmarking for the NAP
implementation across sectors will be of great value.
4- Some efforts should be done to support the sustainability of the NAP implementation, such
as binding the NAP to domestically ongoing programs as a domestic source of funding and
incenting. Moreover, encouraging the industry and corporate social responsibilities to
conduct awareness campaigns on the AMR via different means. In addition to having
agreements mandating different sectors to implement the NAP effectively.
5- More information should be shared with the public on the prudent use of antibiotics in
human and animal sectors; which ultimately end in the environment, the AMR crisis, and
what AMR terms mean.
6- The government can better use the local TV, radio, and newspapers as well as periodicals
to share information and raise awareness of the AMR. On the other hand, the concerned
stakeholders must release national and international guidelines on best practices to the
healthcare providers that have to be adequately disseminated. The HCPs play a substantial
role in raising public awareness of AMR.
7- It would be favorable to create a benchmarking system among different One Health sectors
and across different levels to create a competitive environment for raising public awareness
on AMR and how to curb it.
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Appendix (4) –The public awareness questionnaire on antibiotic use and resistance
DEMOGRAPHICS
To begin, please record the gender
1. Male
2. Female
And what age are you now?
1. < 18
2. 18-24
3. 25-34
4. 35-44
5. 45-54
6. 55-64
7. 65+
In which of these regions do you live?
Drop down a list of Egypt's governorates
And which of these best describes where you live?
1. Urban – within a densely populated city/town
2. Suburban – in a suburb of a city/town
3. Rural – outside of a city/town, e.g., village/countryside/farming area
What is the highest degree or level of school you have completed?
If currently enrolled, highest degree received.
1. Elementary schooling completed الشهادة االبتدائية
2. 12th grade or less, no diploma/qualifications الشهادة االعدادية
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3. High school graduate with diploma/qualifications الشهادة الثانوية أو دبلوم فنى
4.. Bachelor’s degree شهادة جامعية
5. Master’s/Professional degree شهادة ماجيستير
6. Doctorate degree شهادة دكتوراة
7. other, mention:…….
Do you have a medical background? هل لديك خلفية طبية علمية؟
1. Yes (specify:--------)
2. No
Which of these best describes your household composition أى من التالى يصف حالتك االجتماعية
1. 1 Single adult only شخص بالغ اعذب
2. 1 Single adult and at least 1 child under 16 شخص بالغ مطلق و لديه طفل تحت سن السادسة عشر
3. Married / domestic partnership - adults-only متزوج
4. Married / domestic partnership and at least 1 child under 16 متزوج و لديه طفل تحت سن السادسة عشر
MAIN QUESTIONNAIRE
USE OF ANTIBIOTICS
1) When did you last take antibiotics? ً متى اخر مرة تناولت فيها مضادا ً حيويا
1. In the last month فى هذا الشهر
2. In the last 6 months فى آخر ستة أشهر
3. In the last year فى هذا العام
4. More than a year ago منذ أكثر من عام
5. Never ً لم اتناول مضادا ً حيويا ً مطلقا
99. Can’t remember ال اتذكر
If ‘Never’ code 5, go straight to Question 5.
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2) On that occasion, did you get the antibiotics (or a prescription for them) from a doctor or
pharmacist? هل من قام بوصفها لك الطبيب أو الصيدلى؟
1. Yes نعم
2. No ال
99. Can’t remember ال اتذكر
3) On that occasion, did you get advice from a doctor or pharmacist on how to take them?
هل تم توضيح كيفية استخدام المضاد الحيوى من قبل الطبيب أو الصيدلى؟
1. Yes, I received advice on how to take them (e.g. with food, for 7 days)  تلقيت االرشادات حول،نعم
)... و هكذا، أيام7  لمدة،كيفية تناول المضاد الحيوى (مع األكل
2. No ال
99. Can’t remember ال اتذكر
4) On that occasion, where did you get the antibiotics? من أين حصلت على المضاد الحيوى
1. Medical store or pharmacy الصيدلية
2. Stall or hawker
3. The internet االنترنت
4. Friend or family member صديق أو احد أفراد العائلة
5. I had them saved up from a previous time لديك من مرة سابقة
6. Somewhere/someone else مكان|شخص آخر
99. Can’t remember ال اتذكر
KNOWLEDGE ABOUT ANTIBIOTICS
5) When should you stop taking antibiotics once you've begun treatment? متى تعتقد انه يجب
التوقف عن استخدام المضاد الحيوى؟
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1. When you feel better عندما تشعر بتحسن
2. When you’ve taken all of the antibiotics as directed عندما تنتهى من جميع الحبيبات كما تم توجيهك
99. Do not know ال أعرف
6) Do you think this statement is ‘true’ or ‘false’? هل تعتقد أن هذه العبارة صحيحة أم خاطئة؟
“It’s okay to use antibiotics that were given to a friend or family member, as long as they were
used to treat the same illness” "ال بأس من تناول المضاد الحيوى الذى تم اعطائه لقريب | صديق يعانى من نفس

".المرض الذى أعانى منه
1. True صحيحة
2. False خاطئة
99. Don’t know ال أعرف
7) Do you think this statement is ‘true’ or ‘false’?
"It's okay to buy the same antibiotics, or request these from a doctor if you're sick and they
helped you get better when you had the same symptoms before"  ال بأس من شراء،ً"اذا كنت مريضا

"نفس المضاد الحيوى | أو طلبه من الطبيب الذى تحسنت عليه من قبل عندما كنت تعانى من نفس األعراض؟
1. True
2. False
99. Don’t know
8) Do you think these conditions can be treated with antibiotics? هل تعتقد أن هذه األمراض ت ُعالج
بالمضادات الحيوية؟
1. HIV/AIDS مرض نقص المناعة المكتسبة|اإليدز
2. Gonorrhoea السيالن
3. Bladder infection or urinary tract infection (UTI) التهاب الجهاز البولى \ عدوى المثانة
4. Diarrhoea االسهال
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5. Cold and flu البرد و االنفلونزا
6. Fever الحمى
7. Malaria المالريا
8. Measles الحصبة
9. Skin or wound infection عدوى الجلد\التهاب الجروح
10. Sore throat التهاب الحلق
11. Body aches آالم بالجسم
12. Headaches الصداع
KNOWLEDGE ABOUT ANTIBIOTIC RESISTANCE
9) Have you heard of any of the following terms
هل سمعت من قبل عن أى من اآلتى
1. Antibiotic resistance مقاومة البكتريا للمضادات الحيوية
2. Superbugs الخوارق
3. Antimicrobial resistance مقاومة الميكروبات لمضادات الميكروبات
4. AMR
5. Drug resistance مقاومة الدواء
6. Antibiotic-resistant bacteria بكتريا مقاومة للمضادات الحيوية
11. Ask if answered YES @ 9) to ‘Antibiotic Resistance’  مقاومة:اذا كانت اإلجابة نعم فى السؤال السابق
البكتريا للمضادات الحيوية ؟
Where did you hear about the term: ‘Antibiotic Resistance’? من أين سمعت عن مقاومة البكتريا للمضادات
الحيوية
Show list: Code all mentions
1. Doctor or nurse طبيب أو ممرض
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2. Pharmacist صيدلى
3. Family member or friend (including on social media) )قريب\صديق (مواقع التواصل االجتماعى
4. Media (newspaper, TV, radio) ) الراديو، التلفاز،اإلعالم (الجرائد
5. Specific campaign حمالت خاصة
6. Other اخرى
99. Can’t remember

ال أتذكر

12. Ask if answered YES @ 9) to ‘Superbugs’  الخوارق:اذا كانت اإلجابة نعم فى السؤال السابق
Where did you hear about the term: ‘Superbugs’? من أين سمعت عن الخوارق؟
Show list: Code all mentions
1. Doctor or nurse
2. Pharmacist
3. Family member or friend (including on social media)
4. Media (newspaper, TV, radio)
5. Specific campaign
6. Other
99. Can’t remember
13. Ask if answered YES @ 9) to ‘Antimicrobial Resistance’ :اذا كانت اإلجابة نعم فى السؤال السابق
مقاومة الميكروبات لمضادات الميكروبات؟
Where did you hear about the term: ‘Antimicrobial resistance’? من أين سمعت عن مقاومة الميكروبات
لمضادات الميكروبات؟
Show list: Code all mentions
1. Doctor or nurse
2. Pharmacist
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3. Family member or friend (including on social media)
4. Media (newspaper, TV, radio)
5. Specific campaign
6. Other
99. Can’t remember
14. Ask if answered YES @ 9) to ‘AMR’  مصطلح: اذا كانت اإلجابة نعم فى السؤال السابقAMR
Where did you hear about the term: ‘AMR’?  مصطلحAMR من أين سمعت عن
Show list: Code all mentions
1. Doctor or nurse
2. Pharmacist
3. Family member or friend (including on social media)
4. Media (newspaper, TV, radio)
5. Specific campaign
6. Other
99. Can’t remember
15. Ask if answered YES @ 9) to ‘Drug resistance’ اذا كانت اإلجابة نعم فى السؤال السابق
Where did you hear about the term: ‘Drug resistance’?من أين سمعت عن مقاومة الدواء
Show list: Code all mentions
1. Doctor or nurse
2. Pharmacist
3. Family member or friend (including on social media)
4. Media (newspaper, TV, radio)
5. Specific campaign
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6. Other
99. Can’t remember
16. Ask if answered YES @ 9) to ‘Antibiotic-resistant bacteria’ اذا كانت اإلجابة نعم فى السؤال السابق
Where did you hear about the term: ‘Antibiotic-resistant bacteria’? من أين سمعت عن بكتريا مقاومة
للمضادات الحيوية
Show list: Code all mentions
1. Doctor or nurse
2. Pharmacist
3. Family member or friend (including on social media)
4. Media (newspaper, TV, radio)
5. Specific campaign
6. Other
99. Can’t remember
17) Please indicate whether you think the following statements are 'true' or 'false' هل تعتقد أن
هذه الجملة صحيحة أم خاطئة
Single Code per statement
Rotate order asked
1. Antibiotic resistance occurs when your body becomes resistant to antibiotics and they no longer
work as well .تحدث مقاومة المضادات الحيوية عندما ال يستجيب الجسم لها و يصبح مقاوما ً لها
2. Many infections are becoming increasingly resistant to treatment by antibiotics كثير من األمراض
أصبحت أكثر مقاومة للمضادات الحيوية
3. If bacteria are resistant to antibiotics, it can be very difficult or impossible to treat the infections
they cause  يصبح من الصعب أو المستحيل عالج العدوى البكتيرية،فى حالة مقاومة البكتريا للمضادات الحيوية
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4. Antibiotic resistance is an issue that could affect me or my family مقاومة المضادات الحيوية يمكن أن
.تصيبنى أو تصيب أحدا ً من عائلتى
5. Antibiotic resistance is an issue in other countries but not here مقاومة المضادات الحيوية تمثل خطرا ً فى
.الدول األخرى ولكن ال تمثل خطراً هنا
6. Antibiotic resistance is only a problem for people who take antibiotics regularly مقاومة المضادات
 الحيوية تمثل مشكلة.فقط لمن يتناولون المضادات الحيوية بانتظام
7. Bacteria which are resistant to antibiotics can be spread from person to person تستطيع أن تنتقل
.البكتريا المقاومة للمضادات الحيوية من شخص لآلخر
8. Antibiotic-resistant infections could make medical procedures like surgery, organ transplants
and cancer treatment much more dangerous يمكن أن تجعل العدوى من البكتريا المقاومة للمضادات الحيوية زيادة
. و عالج األورام، و زراعة أعضاء،خطورة العملية الجراحية
18) On the scale shown, how much do you agree the following actions would help address the
problem of antibiotic resistance? الى أى مدى توافق على أن الفعل اآلتى قد يساعد على احتواء مشكلة مقاومة
الميكروبات للمضادات الحيوية
Single Code per statement
Rotate order asked
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19) On the scale shown, how much do you agree with following statement الى أى مدى توافق
على العبارة اآلتية
Single Code per statement
Rotate order asked
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USE OF ANTIBIOTICS IN AGRICULTURE
20) Do you think antibiotics are widely used in agriculture (including in food-producing
animals) in your country?
1. Yes
2. No
99. Don’t know
(Write brief explanation of AMR and its implications)
CITIZEN'S EXPECTATION FROM THE GOVERNMENT
21) To what extent do you think the NAP governance's activities towards the AMR:

COMMUNICATION AND INFORMATION SHARING:
22) How do you get most of your information about AMR? Choose no more than two
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23) How would you prefer to obtain information about AMR? Choose no more than two
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